<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Pfizer - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XpoMqwpAICEAABKI4YsAAADL","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Pfizer","wgTitle":"Pfizer","wgCurRevisionId":951294906,"wgRevisionId":951294906,"wgArticleId":62304,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Pfizer","wgRelevantArticleId":62304,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Pfizer_Inc.","wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,
"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Pfizer","wgCoordinates":{"lat":41.3343429,"lon":-72.06795},"wgWikibaseItemId":"Q206921","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1
,"mainMenuExpanded":!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["mediawiki.action.view.redirect","site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP",
"ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.28"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Pfizer.svg/1200px-Pfizer.svg.png"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Pfizer&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Pfizer&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Pfizer"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Pfizer rootpage-Pfizer stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Pfizer" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Pfizer" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Pfizer</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Pfizer" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Pfizer" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"><span class="mw-redirectedfrom">&#160;&#160;(Redirected from <a href="/w/index.php?title=Pfizer_Inc.&amp;redirect=no" class="mw-redirect" title="Pfizer Inc.">Pfizer Inc.</a>)</span></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0">
<p>  
 
<span style="font-size: small;"><span id="coordinates"><a href="/wiki/Geographic_coordinate_system" title="Geographic coordinate system">Coordinates</a>: <span class="plainlinks nourlexpansion"><a class="external text" href="//tools.wmflabs.org/geohack/geohack.php?pagename=Pfizer&amp;params=41.3343429_N_72.06795_W_"><span class="geo-nondefault"><span class="geo-dms" title="Maps, aerial photos, and other data for this location"><span class="latitude">41°20′04″N</span> <span class="longitude">72°04′05″W</span></span></span><span class="geo-multi-punct">﻿ / ﻿</span><span class="geo-default"><span class="geo-dec" title="Maps, aerial photos, and other data for this location">41.3343429°N 72.06795°W</span><span style="display:none">﻿ / <span class="geo">41.3343429; -72.06795</span></span></span></a></span></span></span>
</p>
<p><b>Pfizer Inc.</b> (<span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt"><a href="/wiki/Help:IPA/English" title="Help:IPA/English">/<span style="border-bottom:1px dotted"><span title="/ˈ/: primary stress follows">ˈ</span><span title="'f' in 'find'">f</span><span title="/aɪ/: 'i' in 'tide'">aɪ</span><span title="'z' in 'zoom'">z</span><span title="/ər/: 'er' in 'letter'">ər</span></span>/</a></span></span>)<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">[3]</a></sup> is an <a href="/wiki/United_States" title="United States">American</a> <a href="/wiki/Multinational_corporation" title="Multinational corporation">multinational</a> <a href="/wiki/Pharmaceutical" class="mw-redirect" title="Pharmaceutical">pharmaceutical</a> corporation headquartered in <a href="/wiki/New_York_City" title="New York City">New York City</a>. It is one of the world's largest pharmaceutical companies.<sup id="cite_ref-businessweek_2012_4-0" class="reference"><a href="#cite_note-businessweek_2012-4">[4]</a></sup> It is listed on the <a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">New York Stock Exchange</a>, and its shares have been a component of the <a href="/wiki/Dow_Jones_Industrial_Average" title="Dow Jones Industrial Average">Dow Jones Industrial Average</a> since 2004.<sup id="cite_ref-Dow_Pfizer_5-0" class="reference"><a href="#cite_note-Dow_Pfizer-5">[5]</a></sup> Pfizer ranked No. 57 on the 2018 <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a> list of the largest United States corporations by total revenue.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup></p><table class="infobox vcard" style="width:22em"><caption class="fn org">Pfizer Inc.</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Pfizer.svg" class="image"><img alt="Pfizer.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Pfizer.svg/150px-Pfizer.svg.png" decoding="async" width="150" height="87" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Pfizer.svg/225px-Pfizer.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Pfizer.svg/300px-Pfizer.svg.png 2x" data-file-width="200" data-file-height="116"></a></td></tr><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Pfizerworldheadquartersentrance.jpg" class="image"><img alt="Pfizerworldheadquartersentrance.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/08/Pfizerworldheadquartersentrance.jpg/250px-Pfizerworldheadquartersentrance.jpg" decoding="async" width="250" height="170" data-file-width="4908" data-file-height="3330"></a><div>Entrance to Pfizer headquarters</div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><div class="plainlist"><ul><li><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:PFE">PFE</a></li><li><a href="/wiki/DJIA" class="mw-redirect" title="DJIA">DJIA</a> component</li><li><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100</a> component</li><li><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500</a> component</li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US7170811035">US7170811035 </a><a href="https://www.wikidata.org/wiki/Q206921?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceutical" class="mw-redirect" title="Pharmaceutical">Pharmaceutical</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1849<span class="noprint">; 171 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1849</span>)</span> in <a href="/wiki/New_York_City" title="New York City">New York City</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founders</th><td class="agent" style="line-height: 1.35em;"><a href="/wiki/Charles_Pfizer" title="Charles Pfizer">Charles Pfizer</a><br><a href="/wiki/Charles_F._Erhart" title="Charles F. Erhart">Charles F. Erhart</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="adr" style="line-height: 1.35em;"><div style="display: inline;" class="locality"><a href="/wiki/42nd_Street_(Manhattan)" title="42nd Street (Manhattan)">235 East 42nd Street</a><br><a href="/wiki/Manhattan" title="Manhattan">Manhattan</a>, <a href="/wiki/New_York_City" title="New York City">New York City</a>, <a href="/wiki/New_York_(state)" title="New York (state)">New York</a> 10017 <a href="/wiki/United_States" title="United States">United States</a></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Area served</div></th><td style="line-height: 1.35em;">Worldwide</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><div class="plainlist">
<ul><li><a href="/wiki/Ian_Read" title="Ian Read">Ian Read</a><br><span style="font-size:85%;">(Executive Chairman)</span></li>
<li><a href="/wiki/Albert_Bourla" class="mw-redirect" title="Albert Bourla">Albert Bourla</a><br><span style="font-size:85%;">(CEO)</span></li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;"><i>See <a href="#Products">list</a></i></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap"><a href="/wiki/United_States_dollar" title="United States dollar">US$</a>51.75 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-pfizerFR2019_1-0" class="reference"><a href="#cite_note-pfizerFR2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$16.30 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-pfizerFR2019_1-1" class="reference"><a href="#cite_note-pfizerFR2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$16.27 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-pfizerFR2019_1-2" class="reference"><a href="#cite_note-pfizerFR2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$167.489 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-pfizerFR2019_1-3" class="reference"><a href="#cite_note-pfizerFR2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$63.14 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-pfizerFR2019_1-4" class="reference"><a href="#cite_note-pfizerFR2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">~88,300 (2019)<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">[2]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="https://www.pfizer.com">Pfizer.com</a></span></td></tr></tbody></table><p>On December 19, 2018, Pfizer announced a joint merger of their consumer healthcare division with UK pharma giant <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>; the British company will maintain a controlling share (listed at 68%).<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup></p><p>The company developed and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Its products include the blockbuster drug Lipitor (<a href="/wiki/Atorvastatin" title="Atorvastatin">atorvastatin</a>), used to lower <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL</a> blood cholesterol; Lyrica (<a href="/wiki/Pregabalin" title="Pregabalin">pregabalin</a>) for neuropathic pain and fibromyalgia; Diflucan (<a href="/wiki/Fluconazole" title="Fluconazole">fluconazole</a>), an oral antifungal medication; Zithromax (<a href="/wiki/Azithromycin" title="Azithromycin">azithromycin</a>), an antibiotic; Viagra (<a href="/wiki/Sildenafil" title="Sildenafil">sildenafil</a>) for erectile dysfunction; and Celebrex (also Celebra, <a href="/wiki/Celecoxib" title="Celecoxib">celecoxib</a>), an anti-inflammatory drug.
</p><p>In 2016, Pfizer Inc. was expected to merge with <a href="/wiki/Allergan" title="Allergan">Allergan</a> to create the Ireland-based "Pfizer plc" in a deal that would have been worth $160 billion.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">[8]</a></sup> The merger was called off in April 2016, however, because of new rules from the United States Treasury against tax inversions, a method of avoiding taxes by merging with a foreign company.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">[9]</a></sup> The company has made the second-largest pharmaceutical settlement with the United States Department of Justice.
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a>
<ul><li class="toclevel-2 tocsection-2"><a href="#2000%E2%80%932010"><span class="tocnumber">1.1</span> <span class="toctext">2000–2010</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-3"><a href="#Warner%E2%80%93Lambert_acquisition"><span class="tocnumber">2</span> <span class="toctext">Warner–Lambert acquisition</span></a>
<ul><li class="toclevel-2 tocsection-4"><a href="#Pharmacia_acquisition"><span class="tocnumber">2.1</span> <span class="toctext">Pharmacia acquisition</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Wyeth_acquisition"><span class="tocnumber">2.2</span> <span class="toctext">Wyeth acquisition</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#King_Pharmaceuticals_acquisition"><span class="tocnumber">2.3</span> <span class="toctext">King Pharmaceuticals acquisition</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#2011%E2%80%93present"><span class="tocnumber">2.4</span> <span class="toctext">2011–present</span></a>
<ul><li class="toclevel-3 tocsection-8"><a href="#Zoetis"><span class="tocnumber">2.4.1</span> <span class="toctext">Zoetis</span></a></li>
<li class="toclevel-3 tocsection-9"><a href="#Attempted_AstraZeneca_acquisition"><span class="tocnumber">2.4.2</span> <span class="toctext">Attempted AstraZeneca acquisition</span></a></li>
<li class="toclevel-3 tocsection-10"><a href="#Hospira"><span class="tocnumber">2.4.3</span> <span class="toctext">Hospira</span></a></li>
<li class="toclevel-3 tocsection-11"><a href="#Attempted_Allergan_acquisition"><span class="tocnumber">2.4.4</span> <span class="toctext">Attempted Allergan acquisition</span></a></li>
</ul></li>
<li class="toclevel-2 tocsection-12"><a href="#Pfizer_re-organisation"><span class="tocnumber">2.5</span> <span class="toctext">Pfizer re-organisation</span></a>
<ul><li class="toclevel-3 tocsection-13"><a href="#Pfizer_Consumer_Healthcare"><span class="tocnumber">2.5.1</span> <span class="toctext">Pfizer Consumer Healthcare</span></a></li>
<li class="toclevel-3 tocsection-14"><a href="#Pfizer_off-patent_drug_business"><span class="tocnumber">2.5.2</span> <span class="toctext">Pfizer off-patent drug business</span></a></li>
</ul></li>
</ul></li>
<li class="toclevel-1 tocsection-15"><a href="#Acquisition_history"><span class="tocnumber">3</span> <span class="toctext">Acquisition history</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Operations"><span class="tocnumber">4</span> <span class="toctext">Operations</span></a>
<ul><li class="toclevel-2 tocsection-17"><a href="#Partnerships"><span class="tocnumber">4.1</span> <span class="toctext">Partnerships</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Research_and_development"><span class="tocnumber">4.2</span> <span class="toctext">Research and development</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-19"><a href="#Products"><span class="tocnumber">5</span> <span class="toctext">Products</span></a>
<ul><li class="toclevel-2 tocsection-20"><a href="#Patented_pharmaceuticals"><span class="tocnumber">5.1</span> <span class="toctext">Patented pharmaceuticals</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Generics"><span class="tocnumber">5.2</span> <span class="toctext">Generics</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-22"><a href="#Promotional_practices"><span class="tocnumber">6</span> <span class="toctext">Promotional practices</span></a></li>
<li class="toclevel-1 tocsection-23"><a href="#Controversies"><span class="tocnumber">7</span> <span class="toctext">Controversies</span></a>
<ul><li class="toclevel-2 tocsection-24"><a href="#Quigley_Co."><span class="tocnumber">7.1</span> <span class="toctext">Quigley Co.</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#Bjork%E2%80%93Shiley_heart_valve"><span class="tocnumber">7.2</span> <span class="toctext">Bjork–Shiley heart valve</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Abdullahi_v._Pfizer,_Inc_and_Trovafloxacin_(Trovan)_Controversy."><span class="tocnumber">7.3</span> <span class="toctext"><i>Abdullahi v. Pfizer, Inc and Trovafloxacin (Trovan) Controversy.</i></span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Retrovirus_lawsuit"><span class="tocnumber">7.4</span> <span class="toctext">Retrovirus lawsuit</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#Blue_Cross_Blue_Shield"><span class="tocnumber">7.5</span> <span class="toctext">Blue Cross Blue Shield</span></a></li>
<li class="toclevel-2 tocsection-29"><a href="#Brigham_Young_University"><span class="tocnumber">7.6</span> <span class="toctext">Brigham Young University</span></a></li>
<li class="toclevel-2 tocsection-30"><a href="#Litigation_in_which_Pfizer_was_not_a_party"><span class="tocnumber">7.7</span> <span class="toctext">Litigation in which Pfizer was not a party</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-31"><a href="#Environmental_record"><span class="tocnumber">8</span> <span class="toctext">Environmental record</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#Political_lobbying"><span class="tocnumber">9</span> <span class="toctext">Political lobbying</span></a></li>
<li class="toclevel-1 tocsection-33"><a href="#Employment_and_diversity"><span class="tocnumber">10</span> <span class="toctext">Employment and diversity</span></a>
<ul><li class="toclevel-2 tocsection-34"><a href="#Management"><span class="tocnumber">10.1</span> <span class="toctext">Management</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-35"><a href="#Involvement_in_developing_world_health_issues"><span class="tocnumber">11</span> <span class="toctext">Involvement in developing world health issues</span></a></li>
<li class="toclevel-1 tocsection-36"><a href="#See_also"><span class="tocnumber">12</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-37"><a href="#References"><span class="tocnumber">13</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-38"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Charlespfizer.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/30/Charlespfizer.jpg/170px-Charlespfizer.jpg" decoding="async" width="170" height="220" class="thumbimage" data-file-width="190" data-file-height="246"></noscript><span class="lazy-image-placeholder" style="width: 170px;height: 220px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/3/30/Charlespfizer.jpg/170px-Charlespfizer.jpg" data-alt="" data-width="170" data-height="220" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Charlespfizer.jpg" class="internal" title="Enlarge"></a></div>Charles Pfizer</div></div></div>
<p>In 1849, Pfizer was founded in <a href="/wiki/New_York_City" title="New York City">New York City</a> by German-American <a href="/wiki/Charles_Pfizer" title="Charles Pfizer">Charles Pfizer</a> and his cousin <a href="/wiki/Charles_F._Erhart" title="Charles F. Erhart">Charles F. Erhart</a> from <a href="/wiki/Ludwigsburg" title="Ludwigsburg">Ludwigsburg</a>, Germany. They launched the chemicals business, Charles Pfizer and Company, from a building at the intersection of Harrison Avenue and Bartlett Street<sup id="cite_ref-Citycyclopedia_10-0" class="reference"><a href="#cite_note-Citycyclopedia-10">[10]</a></sup> in <a href="/wiki/Williamsburg,_Brooklyn" title="Williamsburg, Brooklyn">Williamsburg, Brooklyn</a>, where they produced an <a href="/wiki/Antiparasitic" title="Antiparasitic">antiparasitic</a> called <a href="/wiki/Santonin" title="Santonin">santonin</a>. This was an immediate success, although it was the production of <a href="/wiki/Citric_acid" title="Citric acid">citric acid</a> that led to Pfizer's growth in the 1880s. Pfizer continued to buy property to expand its lab and factory. Pfizer's original administrative headquarters was at 81 Maiden Lane in Manhattan.<sup id="cite_ref-Citycyclopedia_10-1" class="reference"><a href="#cite_note-Citycyclopedia-10">[10]</a></sup></p><p>By 1906, sales totaled $3.4 million.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup></p><p><a href="/wiki/World_War_I" title="World War I">World War I</a> caused a shortage of <a href="/wiki/Calcium_citrate" title="Calcium citrate">calcium citrate</a>, which Pfizer imported from Italy for the manufacture of citric acid, and the company began a search for an alternative supply. Pfizer chemists learned of a fungus that ferments sugar to citric acid, and they were able to commercialize production of citric acid from this source in 1919. The company developed expertise in fermentation technology as a result. These skills were applied to the mass production of the antibiotic <a href="/wiki/Penicillin" title="Penicillin">penicillin</a> during <a href="/wiki/World_War_II" title="World War II">World War II</a> in response to the need to treat injured Allied soldiers; most of the penicillin that went ashore with the troops on <a href="/wiki/D-Day" class="mw-redirect" title="D-Day">D-Day</a> was made by Pfizer.<sup id="cite_ref-Forbes_11-0" class="reference"><a href="#cite_note-Forbes-11">[11]</a></sup></p><p>Penicillin became very inexpensive in the 1940s, and Pfizer searched for new antibiotics with greater profit potential. They discovered <a href="/wiki/Oxytetracycline" title="Oxytetracycline">Terramycin (oxytetracycline)</a> in 1950, and this changed the company from a manufacturer of fine chemicals to a research-based pharmaceutical company. Pfizer developed a drug discovery program focused on in vitro synthesis in order to augment its research in fermentation technology. The company also established an animal health division in 1959 with an 700-acre (2.8 km<sup>2</sup>) farm and research facility in <a href="/wiki/Terre_Haute,_Indiana" title="Terre Haute, Indiana">Terre Haute, Indiana</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup></p><p>By the 1950s, Pfizer had established offices in Belgium, Brazil, Canada, Cuba, Mexico, Panama, Puerto Rico, and the United Kingdom. In 1960, the company moved its medical research laboratory operations out of New York City to a new facility in Groton, Connecticut. In 1980, they launched <a href="/wiki/Piroxicam" title="Piroxicam">Feldene (piroxicam)</a>, a prescription anti-inflammatory medication that became Pfizer's first product to reach one billion dollars in total sales.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12">[12]</a></sup> During the 1980s and 1990s, Pfizer Corporation growth was sustained by the discovery and marketing of Zoloft, Lipitor, Norvasc, Zithromax, Aricept, Diflucan, and Viagra.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">[13]</a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14">[14]</a></sup></p>
<h3 class="in-block"><span id="2000.E2.80.932010"></span><span class="mw-headline" id="2000–2010">2000–2010</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=2" title="Edit section: 2000–2010" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In this decade, Pfizer grew by mergers, including those with <a href="/wiki/Warner%E2%80%93Lambert" title="Warner–Lambert">Warner–Lambert</a> (2000), <a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a> (2003), and <a href="/wiki/Wyeth" title="Wyeth">Wyeth</a> (2009).
</p><p>In 2003, the company acquired <a href="/wiki/Esperion_Therapeutics" title="Esperion Therapeutics">Esperion Therapeutics</a> for $1.3 billion (later selling the unit in 2008), protecting Lipitor from <a href="/wiki/ETC-216" class="mw-redirect" title="ETC-216">ETC-216</a>.<sup id="cite_ref-auto_15-0" class="reference"><a href="#cite_note-auto-15">[15]</a></sup> In 2004, Pfizer announced it would acquire Meridica for $125 million.<sup id="cite_ref-auto_15-1" class="reference"><a href="#cite_note-auto-15">[15]</a></sup> In 2005, the company acquired Vicuron Pharmaceuticals for $1.9 billion, Idun for just less than $300 million and finally Angiosyn for $527 million.<sup id="cite_ref-auto_15-2" class="reference"><a href="#cite_note-auto-15">[15]</a></sup></p><p>On June 26, 2006, Pfizer announced it would sell its Consumer Healthcare unit (manufacturer of <a href="/wiki/Listerine" title="Listerine">Listerine</a>, <a href="/wiki/Nicorette" title="Nicorette">Nicorette</a>, <a href="/wiki/Visine" title="Visine">Visine</a>, <a href="/wiki/Sudafed" class="mw-redirect" title="Sudafed">Sudafed</a> and <a href="/wiki/Neomycin/polymyxin_B/bacitracin" title="Neomycin/polymyxin B/bacitracin">Neosporin</a>) to <a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a> for $16.6 billion.<sup id="cite_ref-investor_dec_2006_16-0" class="reference"><a href="#cite_note-investor_dec_2006-16">[16]</a></sup><sup id="cite_ref-NYT_dec_2006_17-0" class="reference"><a href="#cite_note-NYT_dec_2006-17">[17]</a></sup></p><p>Development of <a href="/wiki/Torcetrapib" title="Torcetrapib">torcetrapib</a>, a drug that increases production of <a href="/wiki/High_density_lipoprotein" class="mw-redirect" title="High density lipoprotein">HDL</a>, or "good cholesterol", which reduces <a href="/wiki/Low_density_lipoprotein" class="mw-redirect" title="Low density lipoprotein">LDL</a> thought to be correlated to heart disease, was cancelled in December 2006. During a Phase III clinical trial involving 15,000 patients, more deaths occurred in the group that took the medicine than expected, and a sixty percent increase in mortality was seen among patients taking the combination of torcetrapib and Lipitor versus Lipitor alone. Lipitor alone was not implicated in the results, but Pfizer lost nearly $1 billion developing the failed drug and the market value of the company plummeted afterwards.<sup id="cite_ref-NYT_2006_18-0" class="reference"><a href="#cite_note-NYT_2006-18">[18]</a></sup><sup id="cite_ref-Berenson_20061203_19-0" class="reference"><a href="#cite_note-Berenson_20061203-19">[19]</a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup> That same year, the company also announced it would acquire PowerMed and Rivax.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">[21]</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup></p><p>In September 2009, Pfizer pleaded guilty to the illegal marketing of the arthritis drug <a href="/wiki/Valdecoxib#2009_settlement_for_off-label_uses_promotions" title="Valdecoxib">Bextra</a> for uses unapproved by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA), and agreed to a $2.3 billion settlement, the largest health care fraud settlement at that time.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">[22]</a></sup></p><p>A July 2010 article in <i><a href="/wiki/Bloomberg_Businessweek" title="Bloomberg Businessweek">BusinessWeek</a></i> reported that Pfizer was seeing more success in its battle against makers of <a href="/wiki/Counterfeit" title="Counterfeit">counterfeit</a> prescription drugs by pursuing civil lawsuits rather than criminal prosecution. Pfizer has hired customs and narcotics experts from all over the globe to track down fakes and assemble evidence that can be used to pursue civil suits for <a href="/wiki/Trademark_infringement" title="Trademark infringement">trademark infringement</a>. Since 2007, Pfizer has spent $3.3 million on investigations and legal fees and recovered about $5.1 million, with another $5 million tied up in ongoing cases.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">[23]</a></sup></p><p>On May 6, 2013, Pfizer told The <a href="/wiki/Associated_Press" title="Associated Press">Associated Press</a> it would begin selling Viagra directly to patients via its website.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">[24]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span id="Warner.E2.80.93Lambert_acquisition"></span><span class="mw-headline" id="Warner–Lambert_acquisition">Warner–Lambert acquisition</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=3" title="Edit section: Warner–Lambert acquisition" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<p>Pfizer acquired <a href="/wiki/Warner%E2%80%93Lambert" title="Warner–Lambert">Warner–Lambert</a> in 2000 for $111.8 billion,<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">[25]</a></sup> at the time, created the second largest pharmaceutical company in the world.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">[26]</a></sup> Warner–Lambert was founded as a <a href="/wiki/Philadelphia,_Pennsylvania" class="mw-redirect" title="Philadelphia, Pennsylvania">Philadelphia</a> drug store in 1856 by William R. Warner. Inventing a tablet-coating process gained Warner a place in the <a href="/wiki/Smithsonian_Institution" title="Smithsonian Institution">Smithsonian Institution</a>. Parke–Davis was founded in <a href="/wiki/Detroit,_Michigan" class="mw-redirect" title="Detroit, Michigan">Detroit</a> in 1866 by Hervey Parke and George Davis. Warner–Lambert took over Parke–Davis in 1976, and acquired <a href="/wiki/Wilkinson_Sword" title="Wilkinson Sword">Wilkinson Sword</a> in 1993 and Agouron Pharmaceuticals in 1999.
</p>
<h3 class="in-block"><span class="mw-headline" id="Pharmacia_acquisition">Pharmacia acquisition</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=4" title="Edit section: Pharmacia acquisition" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2002, Pfizer merged with <a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a>. The merger was again driven in part by the desire to acquire full rights to a product, this time Celebrex (<a href="/wiki/Celecoxib" title="Celecoxib">celecoxib</a>), the <a href="/wiki/COX-2_selective_inhibitor" class="mw-redirect" title="COX-2 selective inhibitor">COX-2 selective inhibitor</a> previously jointly marketed by <a href="/wiki/G._D._Searle_%26_Company" class="mw-redirect" title="G. D. Searle &amp; Company">Searle</a> (acquired by Pharmacia) and Pfizer. In the ensuing years, Pfizer carried out a massive restructuring that resulted in numerous site closures and the loss of jobs including <a href="/wiki/Terre_Haute,_Indiana" title="Terre Haute, Indiana">Terre Haute</a>, Indiana; <a href="/wiki/Holland,_Michigan" title="Holland, Michigan">Holland</a>, Michigan; <a href="/wiki/Groton,_Connecticut" title="Groton, Connecticut">Groton</a>, Connecticut; <a href="/wiki/Brooklyn" title="Brooklyn">Brooklyn</a>, New York; <a href="/wiki/Sandwich,_Kent" title="Sandwich, Kent">Sandwich</a>, UK; and <a href="/wiki/Puerto_Rico" title="Puerto Rico">Puerto Rico</a>.
</p><p>Pharmacia had been formed by a series of mergers and acquisitions from its predecessors, including Searle, <a href="/wiki/Upjohn" title="Upjohn">Upjohn</a> and <a href="/wiki/SUGEN" title="SUGEN">SUGEN</a>.
</p><p>In April 1888, Searle was founded in <a href="/wiki/Omaha,_Nebraska" title="Omaha, Nebraska">Omaha, Nebraska</a> by Gideon Daniel Searle. In 1908, the company was incorporated in <a href="/wiki/Chicago" title="Chicago">Chicago</a>, Illinois. In 1941, the company established headquarters in Skokie, Illinois. It was acquired by the <a href="/wiki/Monsanto_Company" class="mw-redirect" title="Monsanto Company">Monsanto Company</a>, headquartered in <a href="/wiki/St._Louis" title="St. Louis">St. Louis</a>, Missouri, in 1985.
</p><p>The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in <a href="/wiki/Kalamazoo,_Michigan" title="Kalamazoo, Michigan">Kalamazoo, Michigan</a>, by Dr. <a href="/wiki/William_E._Upjohn" title="William E. Upjohn">William E. Upjohn</a>, a graduate of the <a href="/wiki/University_of_Michigan" title="University of Michigan">University of Michigan</a> medical school. The company was originally formed to make friable pills, which were designed to be easily digested.  Greenstone was founded in 1993 by Upjohn as a generics division.<sup id="cite_ref-PT2008_27-0" class="reference"><a href="#cite_note-PT2008-27">[27]</a></sup> In 1995, Upjohn merged with Pharmacia, to form <a href="/wiki/Pharmacia_%26_Upjohn" title="Pharmacia &amp; Upjohn">Pharmacia &amp; Upjohn</a>. Pharmacia was created in April 2000 through the merger of Pharmacia &amp; Upjohn with the Monsanto Company and its G.D. Searle unit. The merged company was based in Peapack, New Jersey. The agricultural division was spun off from Pharmacia, as Monsanto, in preparation for the close of the acquisition by Pfizer.<sup id="cite_ref-urlPharmacia_to_Spin_Off_Monsanto_Stake,_Less_Than_2_Years_After_Firms_Merger_Wall_Street_Journal_28nov01_28-0" class="reference"><a href="#cite_note-urlPharmacia_to_Spin_Off_Monsanto_Stake,_Less_Than_2_Years_After_Firms_Merger_Wall_Street_Journal_28nov01-28">[28]</a></sup></p><p>SUGEN, a company focused on <a href="/wiki/Protein_kinase" title="Protein kinase">protein kinase</a> inhibitors, was founded in 1991 in <a href="/wiki/Redwood_City,_California" title="Redwood City, California">Redwood City, California</a>, and acquired by <a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a> in 1999. The company pioneered the use of ATP-mimetic small molecules to block <a href="/wiki/Signal_transduction" title="Signal transduction">signal transduction</a>. After the Pfizer merger, the SUGEN site was shut down in 2003, with the loss of over 300 jobs, and several programs were transferred to Pfizer. These included <a href="/wiki/Sunitinib" title="Sunitinib">sunitinib</a> (Sutent), which was approved for human use by the FDA in January 2006, passed $1 billion in annual revenues for Pfizer in 2010.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">[29]</a></sup> A related compound, SU11654 (<a href="/wiki/Toceranib" title="Toceranib">Toceranib</a>), was also approved for <a href="/wiki/Cancer_in_dogs" title="Cancer in dogs">canine tumors</a>, and the <a href="/wiki/ALK_inhibitor" title="ALK inhibitor">ALK inhibitor</a> <a href="/wiki/Crizotinib" title="Crizotinib">Crizotinib</a> also grew out of a SUGEN program.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">[30]</a></sup></p><p>In 2003, the new Pfizer made Greenstone (originally established as a division of Upjohn) its generic division, and focused on selling <a href="/wiki/Authorized_generics" title="Authorized generics">authorized generics</a> of Pfizer's products.<sup id="cite_ref-PT2008_27-1" class="reference"><a href="#cite_note-PT2008-27">[27]</a></sup><sup id="cite_ref-31" class="reference"><a href="#cite_note-31">[31]</a></sup></p><p>In 2008, Pfizer announced 275 job cuts at the Kalamazoo manufacturing facility. Kalamazoo was previously the world headquarters for the Upjohn Company.<sup id="cite_ref-urlPfizer_plant_in_Michigan_to_cut_275_-_FiercePharma_32-0" class="reference"><a href="#cite_note-urlPfizer_plant_in_Michigan_to_cut_275_-_FiercePharma-32">[32]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Wyeth_acquisition">Wyeth acquisition</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=5" title="Edit section: Wyeth acquisition" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>On January 26, 2009, after more than a year of talks between the two companies, Pfizer agreed to buy pharmaceuticals rival <a href="/wiki/Wyeth" title="Wyeth">Wyeth</a> for a combined US$68 billion in cash, shares and loans, including some US$22.5 billion lent by five major <a href="/wiki/Wall_Street" title="Wall Street">Wall Street</a> banks. The deal cemented Pfizer's position as the largest pharmaceutical company in the world, with the merged company generating over US$20 billion in cash each year, and was the largest corporate merger since <a href="/wiki/AT%26T" title="AT&amp;T">AT&amp;T</a> and <a href="/wiki/BellSouth" title="BellSouth">BellSouth</a>'s US$70 billion deal in March 2006.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">[33]</a></sup> The combined company was expected to save US$4 billion annually through streamlining; however, as part of the deal, both companies must repatriate billions of dollars in revenue from foreign sources to the United States, which will result in higher tax costs. The acquisition was completed on October 15, 2009, making Wyeth a wholly owned subsidiary of Pfizer.<sup id="cite_ref-PfizerWyeth_34-0" class="reference"><a href="#cite_note-PfizerWyeth-34">[34]</a></sup></p><p>The merger was broadly criticized. <a href="/wiki/Harvard_Business_School" title="Harvard Business School">Harvard Business School</a>'s Gary Pisano told <a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a>, "the record of big mergers and acquisitions in Big Pharma has just not been good. There's just been an enormous amount of shareholder wealth destroyed."<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">[35]</a></sup> Analysts said at the time, "The Warner–Lambert and Pharmacia mergers do not appear to have achieved gains for shareholders, so it is unclear who benefits from the Wyeth–Pfizer merger to many critics."<sup id="cite_ref-Matthew_36-0" class="reference"><a href="#cite_note-Matthew-36">[36]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="King_Pharmaceuticals_acquisition">King Pharmaceuticals acquisition</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=6" title="Edit section: King Pharmaceuticals acquisition" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In October 2010, Pfizer agreed to buy <a href="/wiki/King_Pharmaceuticals" title="King Pharmaceuticals">King Pharmaceuticals</a> for $3.6 billion in cash or $14.25 per share: an approximately 40% premium over King's closing share price October 11, 2010.<sup id="cite_ref-htanna_37-0" class="reference"><a href="#cite_note-htanna-37">[37]</a></sup></p>
<h3 class="in-block"><span id="2011.E2.80.93present"></span><span class="mw-headline" id="2011–present">2011–present</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=7" title="Edit section: 2011–present" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In February 2011, it was announced that Pfizer was to close its UK research and development facility (formerly also a manufacturing plant) in <a href="/wiki/Sandwich,_Kent" title="Sandwich, Kent">Sandwich</a>, Kent, which at the time employed 2,400 people.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">[38]</a></sup> However, as of 2014, Pfizer has a reduced presence at the site;<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">[39]</a></sup> it also has a UK research unit in <a href="/wiki/Cambridge" title="Cambridge">Cambridge</a>.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">[40]</a></sup></p><p>On September 4, 2012, the FDA approved a Pfizer pill for a rare type of <a href="/wiki/Leukemia" title="Leukemia">leukemia</a>. The medicine, called Bosulif, treats <a href="/wiki/Chronic_myelogenous_leukemia" title="Chronic myelogenous leukemia">chronic myelogenous leukemia</a> (CML), a blood and <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> disease that usually affects older adults.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">[41]</a></sup></p><p>In July 2014, the company announced it would acquire Innopharma for $225 million, plus up to $135 million in milestone payments, in a deal that expanded Pfizer's range of generic and injectable drugs.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">[42]</a></sup></p><p>On January 5, 2015, the company announced it would acquire a controlling interest in <a href="/w/index.php?title=Redvax&amp;action=edit&amp;redlink=1" class="new" title="Redvax (page does not exist)">Redvax</a> for an undisclosed sum. This deal expanded the company's vaccine portfolio targeting human <a href="/wiki/Cytomegalovirus" title="Cytomegalovirus">cytomegalovirus</a>.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">[43]</a></sup> In March 2015, the company announced it would restart its collaboration with <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly</a> surrounding the phase III trial of <a href="/wiki/Tanezumab" title="Tanezumab">Tanezumab</a>. Pfizer is expected to receive an upfront sum of $200 million.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">[44]</a></sup> In June 2015, the company acquired two <a href="/wiki/Meningitis" title="Meningitis">meningitis</a> drugs from <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>—Nimenrix and <a href="/wiki/Mencevax" class="mw-redirect" title="Mencevax">Mencevax</a>—for around $130 million, expanding the company's <a href="/wiki/Meningococcal_disease" title="Meningococcal disease">meningococcal disease</a> portfolio of drugs.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">[45]</a></sup></p><p>In May 2016, the company announced it would acquire <a href="/wiki/Anacor_Pharmaceuticals" class="mw-redirect" title="Anacor Pharmaceuticals">Anacor Pharmaceuticals</a> for $5.2 billion, expanding the companies portfolio in both inflammation and immunology drugs areas.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">[46]</a></sup> On their final trading day, Anacor shares traded for $99.20 each, giving Anacor a market capitalisation of $4.5 billion. In August, the company made a $40 million bid for the assets of the now bankrupt <a href="/w/index.php?title=BIND_Therapeutics&amp;action=edit&amp;redlink=1" class="new" title="BIND Therapeutics (page does not exist)">BIND Therapeutics</a> through the <a href="/wiki/U.S._Bankruptcy_Court" class="mw-redirect" title="U.S. Bankruptcy Court">U.S. Bankruptcy Court</a>.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47">[47]</a></sup> The same month, the company announced it would acquire <a href="/w/index.php?title=Bamboo_Therapeutics&amp;action=edit&amp;redlink=1" class="new" title="Bamboo Therapeutics (page does not exist)">Bamboo Therapeutics</a> for $645 million, expanding the company's gene therapy offerings.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">[48]</a></sup> Later, in August, the company announced the acquisition of cancer drug-maker -  <a href="/wiki/Medivation" title="Medivation">Medivation</a> - for $14 billion.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">[49]</a></sup><sup id="cite_ref-50" class="reference"><a href="#cite_note-50">[50]</a></sup> On Medivation's final day of trading, its shares were valued at $81.44 each, giving an effective market capitalisation of $13.52 billion. Two days later, Pfizer announced it would acquire <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZenecas</a> small-molecule antibiotics business for $1.575 billion<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">[51]</a></sup> merging it into its <i>Essential Medicines</i> business<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">[52]</a></sup> In the same month the company licensed the anti-<a href="/wiki/CTLA4" class="mw-redirect" title="CTLA4">CTLA4</a> monoclonal antibody, ONC-392, from <a href="/w/index.php?title=OncoImmune&amp;action=edit&amp;redlink=1" class="new" title="OncoImmune (page does not exist)">OncoImmune</a>.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">[53]</a></sup></p><p>In May 2019 the company announced it would acquire <a href="/w/index.php?title=Therachon&amp;action=edit&amp;redlink=1" class="new" title="Therachon (page does not exist)">Therachon</a> for $810 million, expanding its rare disease portfolio through Theracons recombinant human fibroblast growth factor receptor 3 compound, aimed at treating conditions such as <a href="/wiki/Achondroplasia" title="Achondroplasia">achondroplasia</a>.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">[54]</a></sup> In June, Pfizer announced it would acquire <a href="/wiki/Array_Biopharma" class="mw-redirect" title="Array Biopharma">Array Biopharma</a> for $10.6 billion boosting its oncology pipeline.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">[55]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Zoetis">Zoetis</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=8" title="Edit section: Zoetis" data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Zoetis" title="Zoetis">Zoetis</a></div>
<p>Plans to <a href="/wiki/Corporate_spin-off" title="Corporate spin-off">spin out</a> Zoetis, the Agriculture Division of Pfizer and later Pfizer Animal Health, were announced in 2012. Pfizer filed for registration of a Class A stock with the <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a> on August 13, 2012.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">[56]</a></sup> Zoetis's <a href="/wiki/Initial_public_offering" title="Initial public offering">IPO</a> on February 1, 2013, sold 86.1 million shares for <a href="/wiki/US%24" class="mw-redirect" title="US$">US$</a>2.2 billion.<sup id="cite_ref-NYTIPO_57-0" class="reference"><a href="#cite_note-NYTIPO-57">[57]</a></sup> Pfizer retained 414 million Class B shares, giving it an 83% controlling stake in the firm.<sup id="cite_ref-WSJIPO_58-0" class="reference"><a href="#cite_note-WSJIPO-58">[58]</a></sup> The offering's lead <a href="/wiki/Underwriters" class="mw-redirect" title="Underwriters">underwriters</a> were <a href="/wiki/JPMorgan_Chase" title="JPMorgan Chase">JPMorgan Chase</a>, <a href="/wiki/Bank_of_America" title="Bank of America">Bank of America</a>, <a href="/wiki/Merrill_Lynch" class="mw-redirect" title="Merrill Lynch">Merrill Lynch</a>, and <a href="/wiki/Morgan_Stanley" title="Morgan Stanley">Morgan Stanley</a>.<sup id="cite_ref-NYTIPO_57-1" class="reference"><a href="#cite_note-NYTIPO-57">[57]</a></sup> Most of the money raised through the IPO was used to pay off existing Pfizer debt.<sup id="cite_ref-CBSIPO_59-0" class="reference"><a href="#cite_note-CBSIPO-59">[59]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Attempted_AstraZeneca_acquisition">Attempted AstraZeneca acquisition</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=9" title="Edit section: Attempted AstraZeneca acquisition" data-section="9" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>In April 2014, it was reported that Pfizer had reignited a $100 billion takeover bid for the UK-based <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a>,<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">[60]</a></sup><sup id="cite_ref-61" class="reference"><a href="#cite_note-61">[61]</a></sup> sparking political controversy in the UK,<sup id="cite_ref-62" class="reference"><a href="#cite_note-62">[62]</a></sup> as well as in the US.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">[63]</a></sup> On May 19, 2014, a "final offer" of £55 a share was rejected by the AstraZeneca board, which said the bid was too low and imposed too many risks. If successful, the takeover—the biggest in British history—would have made Pfizer the world's largest drug company.<sup id="cite_ref-PfizerBid_64-0" class="reference"><a href="#cite_note-PfizerBid-64">[64]</a></sup> Hopes for a renewed bid later in the year were dashed when Pfizer signed a major cancer drug deal with <a href="/wiki/Merck_KGaA" class="mw-redirect" title="Merck KGaA">Merck KGaA</a>, selling its sharing rights to develop an experimental <a href="/wiki/Immunotherapy" title="Immunotherapy">immunotherapy</a> drug for a fee of $850 million.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">[65]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Hospira">Hospira</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=10" title="Edit section: Hospira" data-section="10" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>In February 2015, Pfizer and <a href="/wiki/Hospira" title="Hospira">Hospira</a> agreed that Pfizer would acquire Hospira for $15.2 billion,<sup id="cite_ref-nytimes.com_66-0" class="reference"><a href="#cite_note-nytimes.com-66">[66]</a></sup> a deal in which Hospira shareholders would receive $90 in cash for each share they owned.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67">[67]</a></sup><sup id="cite_ref-68" class="reference"><a href="#cite_note-68">[68]</a></sup> News of the deal sent Hospira share prices up from $63.43 to $87.43 on a volume of 60.7 million shares.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69">[69]</a></sup> Including debt, the deal is valued at around $17 billion.<sup id="cite_ref-nytimes.com_66-1" class="reference"><a href="#cite_note-nytimes.com-66">[66]</a></sup> <a href="/wiki/Hospira" title="Hospira">Hospira</a> is the largest producer of generic injectable pharmaceuticals in the world.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70">[70]</a></sup> On the final day of trading, Hospira shares traded for $89.96 each, giving a market capitalisation of $15.56 billion.
</p>
<h4 class="in-block"><span class="mw-headline" id="Attempted_Allergan_acquisition">Attempted Allergan acquisition</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=11" title="Edit section: Attempted Allergan acquisition" data-section="11" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Allergan" title="Allergan">Allergan</a></div>
<p>On November 23, 2015, Pfizer and <a href="/wiki/Allergan,_plc" class="mw-redirect" title="Allergan, plc">Allergan, plc</a> announced their intention to merge for an approximate sum of $160 billion, making it the largest pharmaceutical deal ever, and the third largest corporate merger in history. As part of the deal, the Pfizer CEO, Ian Read, was to remain as CEO and chairman of the new company, to be called "Pfizer plc", with Allergan's CEO, Brent Saunders, becoming president and chief operating officer. As part of the deal, Allergan shareholders would receive 11.3 shares of the company, with Pfizer shareholders receiving one. The terms proposed that the merged company would maintain Allergan's <a href="/wiki/Republic_of_Ireland" title="Republic of Ireland">Irish</a> domicile, resulting in the new company being subject to <a href="/wiki/Corporation_tax" class="mw-redirect" title="Corporation tax">corporation tax</a> at the Irish rate of 12.5%--considerably lower than the 35% rate that Pfizer paid at the time.<sup id="cite_ref-BBC_23_nov_2015_71-0" class="reference"><a href="#cite_note-BBC_23_nov_2015-71">[71]</a></sup> The deal was to constitute a <a href="/wiki/Reverse_merger" class="mw-redirect" title="Reverse merger">reverse merger</a>, whereby Allergan acquired Pfizer, with the new company then changing its name to "Pfizer, plc".<sup id="cite_ref-Genegnews_2015_72-0" class="reference"><a href="#cite_note-Genegnews_2015-72">[72]</a></sup><sup id="cite_ref-bloomberg_22_Nov_2015_73-0" class="reference"><a href="#cite_note-bloomberg_22_Nov_2015-73">[73]</a></sup><sup id="cite_ref-premier_2015_74-0" class="reference"><a href="#cite_note-premier_2015-74">[74]</a></sup> The deal was expected to be completed in the second half of 2016, subject to certain conditions: US and EU approval, approval from both sets of shareholders, and the completion of Allergan's divestiture of its generics division to <a href="/wiki/Teva_Pharmaceuticals" title="Teva Pharmaceuticals">Teva Pharmaceuticals</a> (expected in the first quarter of 2016).<sup id="cite_ref-Genegnews_2015_72-1" class="reference"><a href="#cite_note-Genegnews_2015-72">[72]</a></sup> On April 6, 2016, Pfizer and Allergan announced they would be calling off the merger after the Obama administration introduced new laws intended to limit <a href="/wiki/Corporate_inversion" class="mw-redirect" title="Corporate inversion">corporate tax inversions</a> (the extent to which companies could move their headquarters overseas in order to reduce the amount of taxes they pay).<sup id="cite_ref-75" class="reference"><a href="#cite_note-75">[75]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Pfizer_re-organisation">Pfizer re-organisation</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=12" title="Edit section: Pfizer re-organisation" data-section="12" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2018 Pfizer announced it would reorganise its business into three separate units; a higher-margin innovative medicines division, a lower-margin, off-patent drug division, and a consumer healthcare division, with a view to focussing on higher margin therapies.<sup id="cite_ref-76" class="reference"><a href="#cite_note-76">[76]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Pfizer_Consumer_Healthcare">Pfizer Consumer Healthcare</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=13" title="Edit section: Pfizer Consumer Healthcare" data-section="13" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>In October 2017, reports emerged that Pfizer were undertaking a strategic review of their Consumer Healthcare division, with possible results ranging from a partial or complete spin-off or a direct sale<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">[77]</a></sup> with the divestment expected to raise in the region of $15 billion for one of the largest Over-the-Counter businesses in the world.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">[78]</a></sup> <a href="/wiki/Reckitt_Benckiser" title="Reckitt Benckiser">Reckitt Benckiser</a> expressed interest in bidding for the division earlier in October<sup id="cite_ref-79" class="reference"><a href="#cite_note-79">[79]</a></sup> with <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a>, <a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a>, <a href="/wiki/Procter_%26_Gamble" title="Procter &amp; Gamble">Procter &amp; Gamble</a><sup id="cite_ref-80" class="reference"><a href="#cite_note-80">[80]</a></sup> and <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a> also being linked with bids for the business.<sup id="cite_ref-81" class="reference"><a href="#cite_note-81">[81]</a></sup> On March 22, Reckitt Benckiser pulled out of the deal, a day later GlaxoSmithKline also pulled out.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82">[82]</a></sup></p><p>In December 2018, <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a> announced that it, along with Pfizer, had reached an agreement to merge and combine their consumer healthcare divisions into a single entity. The combined entity would have sales of around £9.8 billon ($12.7 billion), with GSK maintaining a 68% controlling stake in the joint venture. Pfizer would own the remaining 32% shareholding. The deal builds on an earlier 2018 deal where GSK bought out Novartis' stake in the GSK-Novartis consumer healthcare joint business.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83">[83]</a></sup><sup id="cite_ref-84" class="reference"><a href="#cite_note-84">[84]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Pfizer_off-patent_drug_business">Pfizer off-patent drug business</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=14" title="Edit section: Pfizer off-patent drug business" data-section="14" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>In late July 2019, the company announced that it would spin off and merge its off-patent medicine division, Upjohn, with <a href="/wiki/Mylan" title="Mylan">Mylan</a>, forming a brand new pharmaceutical business with sales of around $20 billion.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85">[85]</a></sup> The new combined business will have a portfolio of drugs and brands including the <a href="/wiki/Epi-Pen" class="mw-redirect" title="Epi-Pen">Epi-Pen</a>, <a href="/wiki/Viagra" class="mw-redirect" title="Viagra">Viagra</a>, <a href="/wiki/Lipitor" class="mw-redirect" title="Lipitor">Lipitor</a> and <a href="/wiki/Celebrex" class="mw-redirect" title="Celebrex">Celebrex</a>.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86">[86]</a></sup><sup id="cite_ref-87" class="reference"><a href="#cite_note-87">[87]</a></sup></p><p>The deal will be structured as an all-stock, Reverse Morris Trust transaction:
</p>
<ul><li>Upjohn will be spun off to Pfizer shareholders and then combined with Mylan</li>
<li>Each share of Mylan's stock will be converted into one share of the new company</li>
<li>Pfizer shareholders would own 57% of the combined new company and Mylan shareholders will own 43%</li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Acquisition_history">Acquisition history</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=15" title="Edit section: Acquisition history" data-section="15" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<div class="mw-collapsible mw-collapsed" style="box-sizing:border-box;width:100%;font-size:95%;padding:4px;border:1px #aaa solid;"><div style="font-size:100%;line-height:1.6;font-weight:bold;background:transparent;text-align:center;;">Pfizer Acquisitions</div><div class="mw-collapsible-content" style="background:transparent;text-align:left;;">
<style data-mw-deduplicate="TemplateStyles:r886050385">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url("//upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class="treeview">
<ul><li><b>Pfizer</b> <small>(Founded 1849 as Charles Pfizer &amp; Company)</small>
<ul><li><a href="/wiki/Warner%E2%80%93Lambert" title="Warner–Lambert">Warner–Lambert</a>
<ul><li>William R. Warner <small>(Founded 1856, merged 1955)</small></li>
<li>Lambert Pharmacal Company <small>(Merged 1955)</small></li>
<li>Parke-Davis <small>(Founded 1860, Acq 1976)</small></li>
<li>Wilkinson Sword <small>(Acq 1993, divested 2003)</small></li>
<li>Agouron <small>(Acq 1999)</small></li></ul></li>
<li><a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a> <small>(Acq 2002)</small>
<ul><li><a href="/wiki/Pharmacia_%26_Upjohn" title="Pharmacia &amp; Upjohn">Pharmacia &amp; Upjohn</a> <small>(Merged 2000)</small>
<ul><li><a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a> <small>(Merged 1995)</small>
<ul><li>Farmitalia Carlo Erba</li>
<li>Kabi Pharmacia</li>
<li>Pharmacia Aktiebolaget</li></ul></li>
<li><a href="/wiki/The_Upjohn_Company" class="mw-redirect" title="The Upjohn Company">The Upjohn Company</a> <small>(Merged 1995)</small></li>
<li><a href="/wiki/Monsanto" title="Monsanto">Monsanto</a> <small>(Merged 2000, divested 2002)</small></li>
<li><a href="/wiki/G.D._Searle,_LLC" title="G.D. Searle, LLC">Searle</a> <small>(Merged 2000)</small></li></ul></li></ul></li>
<li>Esperion Therapeutics <small>(Acq 2003, divested 2008)</small></li>
<li>Meridica <small>(Acq 2004)</small></li>
<li>Vicuron Pharmaceuticals <small>(Acq 2005)</small></li>
<li>Idun <small>(Acq 2005)</small></li>
<li>Angiosyn <small>(Acq 2005)</small></li>
<li>Powermed <small>(Acq 2006)</small></li>
<li>Rinat <small>(Acq 2006)</small></li>
<li>Coley Pharmaceutical Group <small>(Acq 2007)</small></li>
<li>CovX <small>(Acq 2007)</small></li>
<li>Encysive Pharmaceuticals Inc <small>(Acq 2008)</small></li>
<li><a href="/wiki/Wyeth" title="Wyeth">Wyeth</a> <small>(Acq 2009)</small>
<ul><li><a href="/wiki/Chef_Boyardee" title="Chef Boyardee">Chef Boyardee</a></li>
<li>S.M.A. Corporation</li>
<li>Ayerst Laboratories <small>(Acq 1943)</small></li>
<li>Fort Dodge Serum Company <small>(Acq 1945)</small></li>
<li><a href="/wiki/Bristol-Myers" class="mw-redirect" title="Bristol-Myers">Bristol-Myers</a> <small>(Animal Health div)</small></li>
<li><a href="/wiki/Parke-Davis" title="Parke-Davis">Parke-Davis</a> <small>(Animal Health div)</small></li>
<li>A.H. Robins</li>
<li>Sherwood Medical <small>(Acq 1982)</small></li>
<li><a href="/wiki/Genetics_Institute,_Inc." class="mw-redirect" title="Genetics Institute, Inc.">Genetics Institute, Inc.</a> <small>(Acq 1992)</small></li>
<li><a href="/wiki/American_Cyanamid" title="American Cyanamid">American Cyanamid</a> <small>(Acq 1994)</small></li>
<li>Lederle Laboratories</li>
<li><a href="/wiki/Solvay_S.A." title="Solvay S.A.">Solvay</a> <small>(Acq 1995, Animal Health div)</small></li></ul></li>
<li><a href="/wiki/King_Pharmaceuticals" title="King Pharmaceuticals">King Pharmaceuticals</a> <small>(Acq 2010)</small>
<ul><li>Monarch Pharmaceuticals, Inc.</li>
<li>King Pharmaceuticals Research and Development, Inc.</li>
<li>Meridian Medical Technologies, Inc.</li>
<li>Parkedale Pharmaceuticals, Inc.</li>
<li>King Pharmaceuticals Canada Inc.</li>
<li>Monarch Pharmaceuticals Ireland Limited</li></ul></li>
<li>Synbiotics Corporation <small>(Acq 2011)</small></li>
<li>Icagen <small>(Acq 2011)</small></li>
<li>Ferrosan <small>(Consumer Health div, Acq 2011)</small></li>
<li>Excaliard Pharmaceuticals <small>(Acq 2011)</small></li>
<li>Alacer Corp <small>(Acq 2012)</small></li>
<li>NextWave Pharmaceuticals, Inc <small>(Acq 2012)</small></li>
<li>Innopharma <small>(Acq 2014)</small></li>
<li>Redvax GmbH <small>(Acq 2014)</small></li>
<li>Hospira <small>(Spun off from Abbott Laboratories 2004, Acq 2015)</small> 
<ul><li>Mayne Pharma Ltd <small>(Acq 2007)</small></li>
<li>Pliva-Croatia</li>
<li><a href="/wiki/Orchid_Chemicals_%26_Pharmaceuticals_Ltd." class="mw-redirect" title="Orchid Chemicals &amp; Pharmaceuticals Ltd.">Orchid Chemicals &amp; Pharmaceuticals Ltd.</a> <small>(Generics &amp; Injectables div, Acq 2009)</small> </li>
<li>Javelin Pharmaceuticals, Inc. <small>(Acq 2010)</small></li>
<li>TheraDoc <small>(Acq 2010)</small></li></ul></li>
<li><a href="/wiki/Anacor_Pharmaceuticals" class="mw-redirect" title="Anacor Pharmaceuticals">Anacor Pharmaceuticals</a> <small>(Acq 2016)</small></li>
<li>Bamboo Therapeutics <small>(Acq 2016)</small></li>
<li><a href="/wiki/Medivation" title="Medivation">Medivation</a> <small>(Acq 2016)</small></li>
<li><a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a> <small>(Small molecule antibiotic div, Acq 2016)</small></li></ul></li></ul></div>
</div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Operations">Operations</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=16" title="Edit section: Operations" data-section="16" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Shinjuku_Bunka_Quint_Building.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/170px-Shinjuku_Bunka_Quint_Building.jpg" decoding="async" width="170" height="227" class="thumbimage" data-file-width="600" data-file-height="800"></noscript><span class="lazy-image-placeholder" style="width: 170px;height: 227px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/170px-Shinjuku_Bunka_Quint_Building.jpg" data-alt="" data-width="170" data-height="227" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Shinjuku_Bunka_Quint_Building.jpg" class="internal" title="Enlarge"></a></div>The headquarters of Pfizer Japan in Tokyo</div></div></div>
<p>Pfizer is organised into nine principal operating divisions: Primary Care, Specialty Care, Oncology, Emerging Markets, Established Products, Consumer Healthcare, Nutrition, Animal Health, and Capsugel.<sup id="cite_ref-leadstruc_88-0" class="reference"><a href="#cite_note-leadstruc-88">[88]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Partnerships">Partnerships</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=17" title="Edit section: Partnerships" data-section="17" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In May 2015, Pfizer and a <a href="/wiki/Bar-Ilan_University" title="Bar-Ilan University">Bar-Ilan University</a> laboratory announced a partnership based on the development of medical <a href="/wiki/DNA_nanotechnology" title="DNA nanotechnology">DNA nanotechnology</a>.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89">[89]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Research_and_development">Research and development</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=18" title="Edit section: Research and development" data-section="18" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Pfizer's research and development activities are organised into two principal groups: the PharmaTherapeutics Research &amp; Development Group, which focuses on the discovery of small molecules and related modalities; and the BioTherapeutics Research &amp; Development Group, which focuses on large-molecule research, including vaccines.<sup id="cite_ref-leadstruc_88-1" class="reference"><a href="#cite_note-leadstruc-88">[88]</a></sup> In 2007, Pfizer invested $8.1 billion in research and development, the largest R&amp;D investment in the pharmaceutical industry.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">[90]</a></sup></p><p>Pfizer has R&amp;D facilities in the following locations:
</p>
<ul><li><a href="/wiki/Pearl_River,_New_York" title="Pearl River, New York">Pearl River, New York</a></li>
<li><a href="/wiki/Groton,_Connecticut" title="Groton, Connecticut">Groton, Connecticut</a> (Largest R&amp;D site)<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2019)">citation needed</span></a></i>]</sup></li>
<li><a href="/wiki/Andover,_Massachusetts" title="Andover, Massachusetts">Andover, Massachusetts</a></li>
<li><a href="/wiki/La_Jolla,_California" class="mw-redirect" title="La Jolla, California">La Jolla, California</a> (around 1,000 staff, focused on cancer drugs);<sup id="cite_ref-91" class="reference"><a href="#cite_note-91">[91]</a></sup></li>
<li><a href="/wiki/South_San_Francisco,_California" title="South San Francisco, California">South San Francisco</a>, California</li>
<li><a href="/wiki/Cambridge,_Massachusetts" title="Cambridge, Massachusetts">Cambridge</a>, Massachusetts</li>
<li><a href="/wiki/St._Louis,_Missouri" class="mw-redirect" title="St. Louis, Missouri">St. Louis</a>, Missouri</li>
<li><a href="/wiki/Sandwich,_Kent" title="Sandwich, Kent">Sandwich</a>, United Kingdom</li>
<li><a href="/wiki/Cambridge" title="Cambridge">Cambridge</a>, United Kingdom.</li>
<li><a href="/wiki/Morrisville,_North_Carolina" title="Morrisville, North Carolina">Morrisville</a>, North Carolina</li>
<li><a href="/wiki/Chennai" title="Chennai">Chennai</a>, India</li></ul><p>In 2007, Pfizer announced plans to close or sell the Loughbeg API facility, located at Loughbeg, <a href="/wiki/Ringaskiddy" title="Ringaskiddy">Ringaskiddy</a>, Cork, Ireland by mid to end of 2008. In 2007, Pfizer announced plans to completely close the Ann Arbor, Nagoya and Amboise Research facilities by the end of 2008, eliminating 2,160 jobs and idling the $300 million Michigan facility, which in recent years had seen expansion worth millions of dollars.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92">[92]</a></sup></p><p>On June 18, 2007, Pfizer announced it would move the Animal Health Research (VMRD) division based in Sandwich, England, to Kalamazoo, Michigan.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93">[93]</a></sup> On February 1, 2011, Pfizer announced the closure of the Research and Development centre in Sandwich, with the loss of 2,400 jobs.<sup id="cite_ref-94" class="reference"><a href="#cite_note-94">[94]</a></sup> Pfizer subsequently announced it would be maintaining a significant presence at Sandwich, with around 650 staff continuing to be based at the site.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95">[95]</a></sup></p><p>On September 1, 2011, Pfizer announced it had agreed to a 10-year lease of more than 180,000 square feet of research space from <a href="/wiki/MIT" class="mw-redirect" title="MIT">MIT</a> in a building to be constructed just north of the MIT campus in Cambridge, Massachusetts. The space will house Pfizer's Cardiovascular, Metabolic and Endocrine Disease Research Unit and its Neuroscience Research Unit; Pfizer anticipated moving into the space once it was completed in late 2013.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96">[96]</a></sup></p><p>As of 2013, products in Pfizer's development pipeline included <a href="/wiki/Dimebon" class="mw-redirect" title="Dimebon">dimebon</a> and <a href="/wiki/Tanezumab" title="Tanezumab">tanezumab</a>.
</p><p>In 2018, Pfizer announced that it would end its work on research into treatments for <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a> and <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a> (a symptom of <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a> and other conditions).  The company stated that approximately 300 researchers would lose their jobs as a result.<sup id="cite_ref-Hiltzik_97-0" class="reference"><a href="#cite_note-Hiltzik-97">[97]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Products">Products</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=19" title="Edit section: Products" data-section="19" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<p>As of 2017, Pfizer split its business into two primary segments: (1) innovative health, which includes branded drugs and vaccines, and (2) essential health. In 2016, innovative health generated $29.2 billion in revenue and essential health generated $23.6 billion.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">[98]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Patented_pharmaceuticals">Patented pharmaceuticals</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=20" title="Edit section: Patented pharmaceuticals" data-section="20" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:US_incidence_of_invasive_streptococcal_disease_before_and_after_vaccine_introduction.jpg" class="image"><noscript><img alt="United States incidence of invasive pneumococcal disease before and after introduction of the 7-valent and 13-valent pneumococcal vaccines." src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/US_incidence_of_invasive_streptococcal_disease_before_and_after_vaccine_introduction.jpg/220px-US_incidence_of_invasive_streptococcal_disease_before_and_after_vaccine_introduction.jpg" decoding="async" width="220" height="132" class="thumbimage" data-file-width="752" data-file-height="452"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 132px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/US_incidence_of_invasive_streptococcal_disease_before_and_after_vaccine_introduction.jpg/220px-US_incidence_of_invasive_streptococcal_disease_before_and_after_vaccine_introduction.jpg" data-alt="United States incidence of invasive pneumococcal disease before and after introduction of the 7-valent and 13-valent pneumococcal vaccines." data-width="220" data-height="132" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:US_incidence_of_invasive_streptococcal_disease_before_and_after_vaccine_introduction.jpg" class="internal" title="Enlarge"></a></div>United States incidence of invasive pneumococcal disease before and after introduction of the 7-valent and 13-valent pneumococcal vaccines.<sup id="cite_ref-cdc.gov_99-0" class="reference"><a href="#cite_note-cdc.gov-99">[99]</a></sup></div></div></div>
<p>Key current and Pfizer products include:
</p>
<ul><li><a href="/wiki/Prevnar" class="mw-redirect" title="Prevnar">Prevnar</a> (13-valent conjugate pneumococcal vaccine) is a vaccine for the prevention of invasive pneumococcal infections. The introduction of the original, 7-valent version of the vaccine in 1999 led to a 75% reduction in the incidence of invasive pneumococcal infections among children under age 5 in the United States. An improved version of the vaccine, providing coverage of 13 bacterial variants, was introduced in early 2010, and granted a patent in India in 2017. As of 2012 the rate of invasive infections among children under age 5 has been reduced by an additional 50%.<sup id="cite_ref-cdc.gov_99-1" class="reference"><a href="#cite_note-cdc.gov-99">[99]</a></sup></li>
<li><a href="/wiki/Lyrica" class="mw-redirect" title="Lyrica">Lyrica</a> (<a href="/wiki/Pregabalin" title="Pregabalin">pregabalin</a>) for <a href="/wiki/Neuropathic_pain" title="Neuropathic pain">neuropathic pain</a>. Sales of Lyrica were $4.6 billion in 2013; the US patent on Lyrica was challenged by generic manufacturers and was upheld in 2014, giving Pfizer exclusivity for Lyrica in the US until 2018.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100">[100]</a></sup></li>
<li>Xeljanz (<a href="/wiki/Tofacitinib" title="Tofacitinib">tofacitinib</a>) for rheumatoid arthritis and ulcerative colitis, which had sales of $1.77 billion in 2018 and in January 2019 it was top drug in the United States for <a href="/wiki/Direct-to-consumer_advertising" title="Direct-to-consumer advertising">direct-to-consumer advertising</a>, passing <a href="/wiki/Adalimumab" title="Adalimumab">Humira</a>.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101">[101]</a></sup></li></ul><div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Zoloft_bottles.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/220px-Zoloft_bottles.jpg" decoding="async" width="220" height="196" class="thumbimage" data-file-width="1223" data-file-height="1088"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 196px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/220px-Zoloft_bottles.jpg" data-alt="" data-width="220" data-height="196" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Zoloft_bottles.jpg" class="internal" title="Enlarge"></a></div>Bottles of the antidepressant Zoloft</div></div></div>
<ul><li class="mw-empty-elt"></ul><h3 class="in-block"><span class="mw-headline" id="Generics">Generics</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=21" title="Edit section: Generics" data-section="21" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Xanax_2_mg.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/12/Xanax_2_mg.jpg/170px-Xanax_2_mg.jpg" decoding="async" width="170" height="252" class="thumbimage" data-file-width="997" data-file-height="1477"></noscript><span class="lazy-image-placeholder" style="width: 170px;height: 252px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/1/12/Xanax_2_mg.jpg/170px-Xanax_2_mg.jpg" data-alt="" data-width="170" data-height="252" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Xanax_2_mg.jpg" class="internal" title="Enlarge"></a></div>Xanax (alprazolam) 2 mg tri-score tablets</div></div></div>
<p>In addition to marketing branded pharmaceuticals, Pfizer is involved in the manufacture and sale of <a href="/wiki/Generic_drug" title="Generic drug">generics</a>. In the US it does this through its Greenstone subsidiary, which it acquired as part of the acquisition of Pharmacia.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102">[102]</a></sup> Pfizer also has a licensing deal in place with <a href="/wiki/Aurobindo_Pharma" title="Aurobindo Pharma">Aurobindo</a>, which grants the former access to a variety of oral solid generic products.<sup id="cite_ref-103" class="reference"><a href="#cite_note-103">[103]</a></sup> 
Key historical generics include:
</p>
<ul><li><a href="/wiki/Atorvastatin" title="Atorvastatin">Atorvastatin</a> (<a href="/wiki/Drug_nomenclature#Publication_policies_for_nonproprietary_and_proprietary_names" title="Drug nomenclature">trade name</a> Lipitor), a <a href="/wiki/Statin" title="Statin">statin</a> for the treatment of <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">hypercholesterolemia</a>. Lipitor was developed by Pfizer legacy company Parke-Davis, a subsidiary of Warner-Lambert and first marketed in 1996.<sup id="cite_ref-FDA_Lipitor_104-0" class="reference"><a href="#cite_note-FDA_Lipitor-104">[104]</a></sup> Although atorvastatin was the fifth drug in the class of <a href="/wiki/Statins" class="mw-redirect" title="Statins">statins</a> to be developed, clinical trials showed that atorvastatin caused a more dramatic reduction in <a href="/wiki/LDL-C" class="mw-redirect" title="LDL-C">LDL-C</a> than the other statin drugs. From 1996 to 2012 under the trade name Lipitor, atorvastatin became the world's best-selling drug of all time, with more than $125 billion in sales over approximately 14.5 years.<sup id="cite_ref-url_Crain_2011_105-0" class="reference"><a href="#cite_note-url_Crain_2011-105">[105]</a></sup> Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."<sup id="cite_ref-url_Crain_2011_105-1" class="reference"><a href="#cite_note-url_Crain_2011-105">[105]</a></sup> The patent expired in 2011.<sup id="cite_ref-CNN_Wire_Staff_106-0" class="reference"><a href="#cite_note-CNN_Wire_Staff-106">[106]</a></sup></li>
<li><a href="/wiki/Diflucan" class="mw-redirect" title="Diflucan">Diflucan</a> (fluconazole), the first orally available treatment for severe fungal infections. Fluconazole is recommended as a first-line treatment in <a href="/wiki/Invasive_candidiasis" title="Invasive candidiasis">invasive candidiasis</a><sup id="cite_ref-107" class="reference"><a href="#cite_note-107">[107]</a></sup> and is widely used in the prophylaxis of severe fungal infections in premature infants.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108">[108]</a></sup> Fluconazole is on the World Health Organization's List of Essential Medicines.<sup id="cite_ref-World_Health_Organization_109-0" class="reference"><a href="#cite_note-World_Health_Organization-109">[109]</a></sup> Patent protection ended in 2004 and 2005.<sup id="cite_ref-110" class="reference"><a href="#cite_note-110">[110]</a></sup></li>
<li><a href="/wiki/Flagyl" class="mw-redirect" title="Flagyl">Flagyl</a> (metronidazole) is a <a href="/wiki/Nitroimidazole" title="Nitroimidazole">nitroimidazole</a> <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a> medication used particularly for <a href="/wiki/Anaerobe" class="mw-redirect" title="Anaerobe">anaerobic</a> <a href="/wiki/Bacterium" class="mw-redirect" title="Bacterium">bacteria</a> and <a href="/wiki/Protozoa" title="Protozoa">protozoa</a>. It is <a href="/wiki/Antibacterial" class="mw-redirect" title="Antibacterial">antibacterial</a> against <a href="/wiki/Anaerobic_organisms" class="mw-redirect" title="Anaerobic organisms">anaerobic organisms</a>, an <a href="/wiki/Amoebicide" class="mw-redirect" title="Amoebicide">amoebicide</a>, and an <a href="/wiki/Antiprotozoal" title="Antiprotozoal">antiprotozoal</a>.<sup id="cite_ref-monograph_111-0" class="reference"><a href="#cite_note-monograph-111">[111]</a></sup> As of 2018, it is second line for first episodes of mild-to-moderate <i><a href="/wiki/Clostridium_difficile_(bacteria)" class="mw-redirect" title="Clostridium difficile (bacteria)">Clostridium difficile</a></i> infection (formerly was first-line).<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">[112]</a></sup> It is on the World Health Organization's List of Essential Medicines.<sup id="cite_ref-World_Health_Organization_109-1" class="reference"><a href="#cite_note-World_Health_Organization-109">[109]</a></sup> The original patent protection ended in 1982, but reformulation <a href="/wiki/Evergreening" title="Evergreening">evergreening</a> occurred thereafter.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113">[113]</a></sup></li>
<li><a href="/wiki/Norvasc" class="mw-redirect" title="Norvasc">Norvasc</a> (amlodipine), an <a href="/wiki/Antihypertensive" class="mw-redirect" title="Antihypertensive">antihypertensive</a> drug of the dihydropyridine calcium channel blocker class. Amlodipine is on the <a href="/wiki/World_Health_Organization%27s_List_of_Essential_Medicines" class="mw-redirect" title="World Health Organization's List of Essential Medicines">World Health Organization's List of Essential Medicines</a>, a list of the most important medication needed in a basic <a href="/wiki/Health_system" title="Health system">health system</a>.<sup id="cite_ref-World_Health_Organization_109-2" class="reference"><a href="#cite_note-World_Health_Organization-109">[109]</a></sup> Patent protection ended in 2007.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114">[114]</a></sup></li>
<li><a href="/wiki/Zithromax" class="mw-redirect" title="Zithromax">Zithromax</a> (azithromycin), a macrolide antibiotic that is recommended by the Infectious Disease Society of America as a first line treatment for certain cases of community-acquired pneumonia.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115">[115]</a></sup> Patent protection ended in 2005.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116">[116]</a></sup></li>
<li><a href="/wiki/Zoloft" class="mw-redirect" title="Zoloft">Zoloft</a> (sertraline), is an <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> of the <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI) class. It was introduced to the market by Pfizer in 1991. Sertraline is primarily prescribed for <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depressive disorder</a> in adult <a href="/wiki/Outpatients" class="mw-redirect" title="Outpatients">outpatients</a> as well as <a href="/wiki/Obsessive-compulsive_disorder" class="mw-redirect" title="Obsessive-compulsive disorder">obsessive–compulsive</a>, <a href="/wiki/Panic_disorder" title="Panic disorder">panic</a>, and <a href="/wiki/Social_anxiety_disorder" title="Social anxiety disorder">social anxiety</a> disorders in both adults and children. In 2011, it was the second-most prescribed antidepressant on the U.S. retail market, with 37 million prescriptions.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117">[117]</a></sup> The patent expired 2006.<sup id="cite_ref-118" class="reference"><a href="#cite_note-118">[118]</a></sup></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Promotional_practices">Promotional practices</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=22" title="Edit section: Promotional practices" data-section="22" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/List_of_largest_pharmaceutical_settlements" title="List of largest pharmaceutical settlements">List of largest pharmaceutical settlements</a> and <a href="/wiki/Franklin_v._Parke-Davis" title="Franklin v. Parke-Davis">Franklin v. Parke-Davis</a></div>
<p>Pfizer has long been known within the industry as one of the more aggressive marketers of their products.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119">[119]</a></sup><sup id="cite_ref-120" class="reference"><a href="#cite_note-120">[120]</a></sup><sup id="cite_ref-121" class="reference"><a href="#cite_note-121">[121]</a></sup> Access to Wyeth internal documents has revealed <a href="/wiki/Pharmaceutical_marketing" title="Pharmaceutical marketing">marketing</a> strategies used to promote <a href="/wiki/Neurontin" class="mw-redirect" title="Neurontin">Neurontin</a> for <a href="/wiki/Off-label_use" title="Off-label use">off-label use</a>.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122">[122]</a></sup> In 1993, the <a href="/wiki/Food_and_Drug_Administration_(United_States)" class="mw-redirect" title="Food and Drug Administration (United States)">U.S. Food and Drug Administration</a> (FDA) approved <a href="/wiki/Gabapentin" title="Gabapentin">gabapentin</a> (Neurontin, Pfizer) only for treatment of <a href="/wiki/Seizures" class="mw-redirect" title="Seizures">seizures</a>. <a href="/wiki/Warner%E2%80%93Lambert" title="Warner–Lambert">Warner–Lambert</a>, which merged with Pfizer in 2000, used activities not usually associated with sales promotion, including <a href="/wiki/Continuing_medical_education" title="Continuing medical education">continuing medical education</a> and <a href="/wiki/Medical_research" title="Medical research">research</a>, sponsored articles about the drug for the medical literature, and alleged suppression of unfavorable study results, to promote gabapentin. Within 5 years the drug was being widely used for the <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> treatment of pain and psychiatric conditions. Warner–Lambert admitted to charges that it violated FDA regulations by <a href="/wiki/List_of_off-label_promotion_pharmaceutical_settlements" title="List of off-label promotion pharmaceutical settlements">promoting the drug</a> for pain, psychiatric conditions, migraine, and other unapproved uses, and paid <a href="/wiki/List_of_Largest_Pharmaceutical_Settlements" class="mw-redirect" title="List of Largest Pharmaceutical Settlements">$430 million</a> to resolve criminal and civil health care liability charges.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">[123]</a></sup><sup id="cite_ref-124" class="reference"><a href="#cite_note-124">[124]</a></sup> A recent Cochrane review concluded that gabapentin is ineffective in migraine prophylaxis.<sup id="cite_ref-125" class="reference"><a href="#cite_note-125">[125]</a></sup> The American Academy of Neurology rates it as having unproven efficacy, while the Canadian Headache Society and the European Federation of Neurological Societies rate its use as being supported by moderate and low-quality evidence, respectively.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126">[126]</a></sup></p><p>In September 2009, Pfizer agreed to pay <a href="/wiki/List_of_Largest_Pharmaceutical_Settlements" class="mw-redirect" title="List of Largest Pharmaceutical Settlements">$2.3 billion</a> to settle civil and criminal allegations that it had illegally marketed four drugs—<a href="/wiki/Bextra" class="mw-redirect" title="Bextra">Bextra</a>, <a href="/wiki/Geodon" class="mw-redirect" title="Geodon">Geodon</a>, <a href="/wiki/Zyvox" class="mw-redirect" title="Zyvox">Zyvox</a>, and <a href="/wiki/Lyrica" class="mw-redirect" title="Lyrica">Lyrica</a>—for non-approved uses; it was Pfizer's fourth such settlement in a decade.<sup id="cite_ref-2.3_nytimes_127-0" class="reference"><a href="#cite_note-2.3_nytimes-127">[127]</a></sup><sup id="cite_ref-wapo_offlabel_128-0" class="reference"><a href="#cite_note-wapo_offlabel-128">[128]</a></sup><sup id="cite_ref-Pfizer_agrees_record_fraud_fine_129-0" class="reference"><a href="#cite_note-Pfizer_agrees_record_fraud_fine-129">[129]</a></sup> The payment included $1.3 billion in criminal penalties for felony violations of the Food, Drug and Cosmetic Act, and $1 billion to settle allegations it had illegally promoted the drugs for uses that were not approved by the <a href="/wiki/Food_and_Drug_Administration_(United_States)" class="mw-redirect" title="Food and Drug Administration (United States)">U.S. Food and Drug Administration</a> (FDA) and caused <a href="/wiki/False_Claims_Act" title="False Claims Act">false claims</a> to be submitted to Federal and State programs. The criminal fine was the largest ever assessed in the United States up to that time.<sup id="cite_ref-130" class="reference"><a href="#cite_note-130">[130]</a></sup> Pfizer has entered an extensive <a href="/wiki/Corporate_integrity_agreement" title="Corporate integrity agreement">corporate integrity agreement</a> with the Office of Inspector General and will be required to make substantial structural reforms within the company, and maintain the Pfizer website (www.pfizer.com/pmc) to track the company's post marketing commitments. Pfizer had to also put a searchable database of all payments to physicians the company had made on the Pfizer website by March 31, 2010.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131">[131]</a></sup></p><p>Peter Rost was vice president in charge of the endocrinology division at Pharmacia before and during its acquisition by Pfizer. During that time he raised concerns internally about <a href="/wiki/Kickback_(bribery)" title="Kickback (bribery)">kickbacks</a> and off-label marketing of Genotropin, Pharmacia's <a href="/wiki/Human_growth_hormone" class="mw-redirect" title="Human growth hormone">human growth hormone</a> drug. Pfizer reported the Pharmacia marketing practices to the FDA and Department of Justice; Rost was unaware of this and filed an FCA lawsuit against Pfizer. Pfizer kept him on, but isolated him until the FCA suit was unsealed in 2005. The Justice Department declined to intervene, and Pfizer fired him, and he filed a wrongful termination suit against Pfizer.<sup id="cite_ref-Edwards_132-0" class="reference"><a href="#cite_note-Edwards-132">[132]</a></sup> Pfizer won a summary dismissal of the case, with the court ruling that the evidence showed Pfizer had decided to fire Rost prior to learning of his whistleblower activities.<sup id="cite_ref-133" class="reference"><a href="#cite_note-133">[133]</a></sup></p><p>A "whistleblower suit" was filed in 2005 against <a href="/wiki/Wyeth" title="Wyeth">Wyeth</a>, which was acquired by Pfizer in 2009, alleging that the company illegally marketed their drug <a href="/wiki/Rapamune" class="mw-redirect" title="Rapamune">Rapamune</a>. Wyeth is targeted in the suit for off-label marketing, targeting specific doctors and medical facilities to increase sales of Rapamune, trying to get current transplant patients to change from their current transplant drugs to Rapamune and for specifically targeting African-Americans. According to the whistleblowers, Wyeth also provided doctors and hospitals with kickbacks to prescribe the drug in the form of grants, donations and other money.<sup id="cite_ref-134" class="reference"><a href="#cite_note-134">[134]</a></sup><sup id="cite_ref-135" class="reference"><a href="#cite_note-135">[135]</a></sup> In 2013, the company pleaded guilty to criminal mis-branding violations under the Food, Drug and Cosmetic Act. By August 2014 it had paid $491 million in civil and criminal penalties.<sup id="cite_ref-136" class="reference"><a href="#cite_note-136">[136]</a></sup></p><p>According to <i><a href="/wiki/Harper%27s_Magazine" title="Harper's Magazine">Harper's Magazine</a></i> publisher <a href="/wiki/John_R._MacArthur" title="John R. MacArthur">John MacArthur</a>, Pfizer withdrew "between $400,000 and a million dollars" worth of ads from their magazine following an unflattering article on depression medication.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137">[137]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Controversies">Controversies</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=23" title="Edit section: Controversies" data-section="23" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<p>Pfizer is party to a number of lawsuits stemming from its pharmaceutical products as well as the practices of various companies it has merged with or acquired.<sup id="cite_ref-2.3_nytimes_127-1" class="reference"><a href="#cite_note-2.3_nytimes-127">[127]</a></sup><sup id="cite_ref-wapo_offlabel_128-1" class="reference"><a href="#cite_note-wapo_offlabel-128">[128]</a></sup><sup id="cite_ref-Pfizer_agrees_record_fraud_fine_129-1" class="reference"><a href="#cite_note-Pfizer_agrees_record_fraud_fine-129">[129]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Quigley_Co.">Quigley Co.</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=24" title="Edit section: Quigley Co." data-section="24" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Pfizer acquired Quigley in 1968, and the division sold <a href="/wiki/Asbestos" title="Asbestos">asbestos</a>-containing insulation products until the early 1970s.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138">[138]</a></sup> Asbestos victims and Pfizer have been negotiating a settlement deal that calls for Pfizer to pay $430 million to 80 percent of existing plaintiffs. It will also place an additional $535 million into an asbestos settlement trust that will compensate future plaintiffs as well as the remaining 20 percent of current plaintiffs with claims against Pfizer and Quigley. The compensation deal is worth $965 million all up. Of that $535 million, $405 million is in a 40-year note from Pfizer, while $100 million will come from insurance policies.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139">[139]</a></sup></p>
<h3 class="in-block"><span id="Bjork.E2.80.93Shiley_heart_valve"></span><span class="mw-headline" id="Bjork–Shiley_heart_valve">Bjork–Shiley heart valve</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=25" title="Edit section: Bjork–Shiley heart valve" data-section="25" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Pfizer purchased Shiley in 1979 at the onset of its Convexo-Concave valve ordeal, involving the <a href="/wiki/Bjork%E2%80%93Shiley_valve" class="mw-redirect" title="Bjork–Shiley valve">Bjork–Shiley heart valve</a>. Approximately 500 people died when defective valves failed and, in 1994, the United States ruled against Pfizer for ~$200 million.<sup id="cite_ref-140" class="reference"><a href="#cite_note-140">[140]</a></sup><sup id="cite_ref-141" class="reference"><a href="#cite_note-141">[141]</a></sup></p>
<h3 class="in-block"><span id="Abdullahi_v._Pfizer.2C_Inc_and_Trovafloxacin_.28Trovan.29_Controversy."></span><span class="mw-headline" id="Abdullahi_v._Pfizer,_Inc_and_Trovafloxacin_(Trovan)_Controversy."><i>Abdullahi v. Pfizer, Inc and Trovafloxacin (Trovan) Controversy.</i></span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=26" title="Edit section: Abdullahi v. Pfizer, Inc and Trovafloxacin (Trovan) Controversy." data-section="26" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Abdullahi_v._Pfizer,_Inc." title="Abdullahi v. Pfizer, Inc.">Abdullahi v. Pfizer, Inc.</a></div>
<p>In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives and personnel from a contract research organization (CRO) traveled to Kano, Nigeria to set up a clinical trial and administer an experimental <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a>, <a href="/wiki/Trovafloxacin" title="Trovafloxacin">trovafloxacin</a>, to approximately 200 children.<sup id="cite_ref-142" class="reference"><a href="#cite_note-142">[142]</a></sup> Local Kano officials report that more than 50 children died in the experiment, while many others developed mental and physical deformities.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143">[143]</a></sup> The nature and frequency of both fatalities and other adverse outcomes were similar to those historically found among pediatric patients treated for meningitis in sub-Saharan Africa.<sup id="cite_ref-144" class="reference"><a href="#cite_note-144">[144]</a></sup> In 2001, families of the children, as well as the governments of Kano and Nigeria, filed lawsuits regarding the treatment.<sup id="cite_ref-145" class="reference"><a href="#cite_note-145">[145]</a></sup> According to the news program <i><a href="/wiki/Democracy_Now!" title="Democracy Now!">Democracy Now!</a></i>, "[r]esearchers did not obtain signed consent forms, and medical personnel said Pfizer did not tell parents their children were getting the experimental drug."<sup id="cite_ref-DN_146-0" class="reference"><a href="#cite_note-DN-146">[146]</a></sup> The lawsuits also accuse Pfizer of using the outbreak to perform unapproved human testing, as well as allegedly under-dosing a control group being treated with traditional antibiotics in order to skew the results of the trial in favor of Trovan. While the specific facts of the case remain in dispute, both Nigerian medical personnel and at least one Pfizer physician have stated that the trial was conducted without regulatory approval.<sup id="cite_ref-147" class="reference"><a href="#cite_note-147">[147]</a></sup><sup id="cite_ref-148" class="reference"><a href="#cite_note-148">[148]</a></sup></p><p>In 2007, Pfizer published a Statement of Defense letter.<sup id="cite_ref-149" class="reference"><a href="#cite_note-149">[149]</a></sup> The letter states that the drug's oral form was safer and easier to administer, that Trovan had been used safely in over 5000 Americans prior to the Nigerian trial, that mortality in the patients treated by Pfizer was lower than that observed historically in African meningitis epidemics, and that no unusual side effects, unrelated to meningitis, were observed after 4 weeks.
</p><p>In June 2010, the US Supreme Court rejected Pfizer's appeal against a ruling allowing lawsuits by the Nigerian families to proceed.<sup id="cite_ref-150" class="reference"><a href="#cite_note-150">[150]</a></sup></p><p>In December 2010, <a href="/wiki/WikiLeaks" title="WikiLeaks">WikiLeaks</a> released <a href="/wiki/United_States_diplomatic_cables_leak" title="United States diplomatic cables leak">US diplomatic cables</a>, which indicate that Pfizer had hired investigators to find evidence of corruption against Nigerian attorney general Aondoakaa to persuade him to drop legal action.<sup id="cite_ref-151" class="reference"><a href="#cite_note-151">[151]</a></sup> <i><a href="/wiki/Washington_Post" class="mw-redirect" title="Washington Post">Washington Post</a></i> reporter Joe Stephens, who helped break the story in 2000, called these actions "dangerously close to blackmail."<sup id="cite_ref-DN_146-1" class="reference"><a href="#cite_note-DN-146">[146]</a></sup> In response, the company has released a press statement describing the allegations as "preposterous" and stating that they acted in good faith.<sup id="cite_ref-152" class="reference"><a href="#cite_note-152">[152]</a></sup> Aondoakka, who had allegedly demanded bribes from Pfizer in return for a settlement of the case,<sup id="cite_ref-153" class="reference"><a href="#cite_note-153">[153]</a></sup> was declared unfit for office and had his U.S. visa revoked in association with corruption charges in 2010.<sup id="cite_ref-154" class="reference"><a href="#cite_note-154">[154]</a></sup><sup id="cite_ref-155" class="reference"><a href="#cite_note-155">[155]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Retrovirus_lawsuit">Retrovirus lawsuit</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=27" title="Edit section: Retrovirus lawsuit" data-section="27" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>A scientist claims she was infected by a genetically modified virus while working for Pfizer. In her federal lawsuit she says she has been intermittently paralyzed by the Pfizer-designed virus. "McClain, of Deep River, suspects she was inadvertently exposed, through work by a former Pfizer colleague in 2002 or 2003, to an engineered form of the <a href="/wiki/Lentivirus" title="Lentivirus">lentivirus</a>, a virus similar to the one that can lead to acquired immune deficiency syndrome, also known as AIDS."<sup id="cite_ref-156" class="reference"><a href="#cite_note-156">[156]</a></sup> The court found that McClain failed to demonstrate that her illness was caused by exposure to the lentivirus,<sup id="cite_ref-157" class="reference"><a href="#cite_note-157">[157]</a></sup> but also that Pfizer violated whistleblower laws.<sup id="cite_ref-158" class="reference"><a href="#cite_note-158">[158]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Blue_Cross_Blue_Shield">Blue Cross Blue Shield</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=28" title="Edit section: Blue Cross Blue Shield" data-section="28" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Health insurance company <a href="/wiki/Blue_Cross_Blue_Shield" class="mw-redirect" title="Blue Cross Blue Shield">Blue Cross Blue Shield</a> (BCBS) filed a lawsuit against Pfizer for reportedly illegally marketing their drugs <a href="/wiki/Bextra" class="mw-redirect" title="Bextra">Bextra</a>, <a href="/wiki/Geodon" class="mw-redirect" title="Geodon">Geodon</a> and <a href="/wiki/Lyrica" class="mw-redirect" title="Lyrica">Lyrica</a>. BCBS is reporting that Pfizer used "kickbacks" and wrongly persuaded doctors to prescribe the drugs.<sup id="cite_ref-159" class="reference"><a href="#cite_note-159">[159]</a></sup><sup id="cite_ref-160" class="reference"><a href="#cite_note-160">[160]</a></sup> FiercePharma reported that "According to the suit, the drugmaker not only handed out those "misleading" materials on off-label uses, but sent doctors on Caribbean junkets and paid them $2,000 honoraria in return for their listening to lectures about Bextra. More than 5,000 healthcare professionals were entertained at meetings in Bahamas, Virgin Islands, and across the U.S., the suit alleges."<sup id="cite_ref-161" class="reference"><a href="#cite_note-161">[161]</a></sup><sup id="cite_ref-162" class="reference"><a href="#cite_note-162">[162]</a></sup> The case was settled in 2014 for $325M.<sup id="cite_ref-163" class="reference"><a href="#cite_note-163">[163]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Brigham_Young_University">Brigham Young University</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=29" title="Edit section: Brigham Young University" data-section="29" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Controversy arose over the drug "Celebrex". <a href="/wiki/Brigham_Young_University" title="Brigham Young University">Brigham Young University</a> (BYU) said that a professor of chemistry, Dr. <a href="/wiki/Daniel_L._Simmons" title="Daniel L. Simmons">Daniel L. Simmons</a>, discovered an enzyme in the 1990s that would later lead towards the development of Celebrex. BYU was originally seeking 15% royalty on sales, which would equate to $9.7 billion. The court filings show that a research agreement was made with <a href="/wiki/Monsanto" title="Monsanto">Monsanto</a>, whose pharmaceutical business was later acquired by Pfizer, to develop a better aspirin. The enzyme that Dr. Simmons claims to have discovered would induce pain and inflammation while causing gastrointestinal problems, which Celebrex is used to reduce those issues. A battle ensued, lasting over six years, because BYU claimed that Pfizer did not give him credit or compensation while Pfizer claims it had met all obligations regarding the Monsanto agreement. This culminated in a $450 million amicable settlement without going to trial. Pfizer said it would take a $450 million charge against first quarter earnings to settle.<sup id="cite_ref-164" class="reference"><a href="#cite_note-164">[164]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Litigation_in_which_Pfizer_was_not_a_party">Litigation in which Pfizer was not a party</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=30" title="Edit section: Litigation in which Pfizer was not a party" data-section="30" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Pfizer was discussed as part of the <a href="/wiki/Kelo_v._New_London" class="mw-redirect" title="Kelo v. New London">Kelo v. New London</a> case that was decided by <a href="/wiki/U.S._Supreme_Court" class="mw-redirect" title="U.S. Supreme Court">U.S. Supreme Court</a> in 2005.  In February 1998 Pfizer announced it would build a research facility in  <a href="/wiki/New_London,_Connecticut" title="New London, Connecticut">New London</a>, Connecticut, and local planners, hoping to promote <a href="/wiki/Economic_development" title="Economic development">economic development</a> and build on the influx of jobs the planned facility would bring to the town, created a plan that included seizing property to redevelop it under <a href="/wiki/Eminent_domain" title="Eminent domain">eminent domain</a>, and local residents sued to stop the seizure.  The case went to the Supreme Court, and with regard to Pfizer, the court cited a prior decision that said: "The record clearly demonstrates that the development plan was not intended to serve the interests of Pfizer, Inc., or any other private entity, but rather, to revitalize the local economy by creating temporary and permanent jobs, generating a significant increase in tax revenue, encouraging spin-off economic activities and maximizing public access to the waterfront”.<sup id="cite_ref-Kelo_165-0" class="reference"><a href="#cite_note-Kelo-165">[165]</a></sup>   The Supreme Court allowed the eminent domain to proceed.<sup id="cite_ref-Kelo_165-1" class="reference"><a href="#cite_note-Kelo-165">[165]</a></sup>  Pfizer opened the facility in 2001 but abandoned it in 2009, angering residents of the town.<sup id="cite_ref-166" class="reference"><a href="#cite_note-166">[166]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Environmental_record">Environmental record</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=31" title="Edit section: Environmental record" data-section="31" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<p>Between 2002 and 2008, Pfizer reduced its greenhouse emissions by 20%,<sup id="cite_ref-167" class="reference"><a href="#cite_note-167">[167]</a></sup> and committed to reducing emissions by an additional 20% by 2012. In 2012 the company was named to the <a href="/wiki/Carbon_Disclosure_Project" title="Carbon Disclosure Project">Carbon Disclosure Project</a>'s Carbon Leadership Index in recognition of its efforts to reduce greenhouse gas emissions.<sup id="cite_ref-168" class="reference"><a href="#cite_note-168">[168]</a></sup></p><p>Pfizer has inherited Wyeth's liabilities in the <a href="/wiki/American_Cyanamid" title="American Cyanamid">American Cyanamid</a> site in Bridgewater, New Jersey. This site is highly toxic and an EPA declared Superfund site. Pfizer has since attempted to remediate this land in order to clean and develop it for future profits and potential public uses.<sup id="cite_ref-169" class="reference"><a href="#cite_note-169">[169]</a></sup> The Sierra Club and the Edison Wetlands Association have come out in opposition to the cleanup plan, arguing that the area is subject to flooding, which could cause pollutants to leach. The EPA considers the plan the most reasonable from considerations of safety and cost-effectiveness, arguing that an alternative plan involving trucking contaminated soil off site could expose cleanup workers. The EPA's position is backed by the environmental watchdog group CRISIS.<sup id="cite_ref-170" class="reference"><a href="#cite_note-170">[170]</a></sup></p><p>In June 2002, a chemical explosion at the Groton plant injured seven people and caused the evacuation of over 100 homes in the surrounding area.<sup id="cite_ref-autogenerated3_171-0" class="reference"><a href="#cite_note-autogenerated3-171">[171]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(9)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Political_lobbying">Political lobbying</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=32" title="Edit section: Political lobbying" data-section="32" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-9 collapsible-block" id="mf-section-9">
<p>Pfizer is a leading member of the <a href="/wiki/U.S._Global_Leadership_Coalition" title="U.S. Global Leadership Coalition">U.S. Global Leadership Coalition</a>, a Washington D.C.-based coalition of over 400 major companies and NGOs that advocates for a larger International Affairs Budget, which funds American diplomatic, humanitarian, and development efforts abroad.<sup id="cite_ref-172" class="reference"><a href="#cite_note-172">[172]</a></sup></p><p>Pfizer is one of the single largest lobbying interests in United States politics. For example, in the first 9 months of 2009 Pfizer spent over $16.3 million on lobbying US congressional lawmakers, making them the sixth largest lobbying interest in the US (following Pharmaceutical Research and Manufacturers of America (PhRMA), which ranked fourth but also represents many of their interests). A spokeswoman for Pfizer said the company “wanted to make sure our voice is heard in this conversation” in regards to the company's expenditure of $25 million in 2010 to lobby health care reform.<sup id="cite_ref-173" class="reference"><a href="#cite_note-173">[173]</a></sup></p><p>According to <a href="/wiki/United_States_Department_of_State" title="United States Department of State">U.S. State Department</a> cables released by the <a href="/wiki/Whistleblower" title="Whistleblower">whistleblower</a> site <a href="/wiki/WikiLeaks" title="WikiLeaks">WikiLeaks</a>, Pfizer "lobbied against New Zealand getting a <a href="/wiki/Free_trade" title="Free trade">free trade</a> agreement with the United States because it objected to New Zealand's restrictive drug buying rules and tried to get rid of New Zealand's former health minister, <a href="/wiki/Helen_Clark" title="Helen Clark">Helen Clark</a>, in 1990.<sup id="cite_ref-NZ_Herald_10695239_174-0" class="reference"><a href="#cite_note-NZ_Herald_10695239-174">[174]</a></sup></p><p>In an example of the <a href="/wiki/Revolving_door_(politics)" title="Revolving door (politics)">revolving door between government and industry</a> in the United States, <a href="/wiki/Scott_Gottlieb" title="Scott Gottlieb">Scott Gotlieb</a>, who resigned as the <a href="/wiki/FDA_commissioner" class="mw-redirect" title="FDA commissioner">US FDA Commissioner</a> in April 2019, joined the Pfizer <a href="/wiki/Board_of_directors" title="Board of directors">board of directors</a> three months later, in July.<sup id="cite_ref-175" class="reference"><a href="#cite_note-175">[175]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(10)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Employment_and_diversity">Employment and diversity</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=33" title="Edit section: Employment and diversity" data-section="33" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-10 collapsible-block" id="mf-section-10">
<p>Since 2004, Pfizer has received a 100% rating every year on the <a href="/wiki/Corporate_Equality_Index" title="Corporate Equality Index">Corporate Equality Index</a>, released by the <a href="/wiki/Human_Rights_Campaign" title="Human Rights Campaign">Human Rights Campaign Foundation</a>.
</p><p>In 2012, Pfizer's Canadian division, which then employed 2,890 people, was named one of <a href="/wiki/Canada%27s_Top_100_Employers#Montreal_Top_15_Winners" title="Canada's Top 100 Employers">Montreal's Top 15 Employers</a>, the only research-based pharmaceutical company to receive this honor.<sup id="cite_ref-176" class="reference"><a href="#cite_note-176">[176]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=34" title="Edit section: Management" data-section="34" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2010, <a href="/wiki/Ian_Read" title="Ian Read">Ian Read</a> took over as CEO from <a href="/wiki/Jeff_Kindler" title="Jeff Kindler">Jeff Kindler</a>. In 2019, Ian Read left the CEO role and became executive chairman, with COO Albert Bouria taking the CEO role.<sup id="cite_ref-177" class="reference"><a href="#cite_note-177">[177]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(11)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Involvement_in_developing_world_health_issues">Involvement in developing world health issues</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=35" title="Edit section: Involvement in developing world health issues" data-section="35" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-11 collapsible-block" id="mf-section-11">
<p>Pfizer makes the anti-fungal drug <a href="/wiki/Fluconazole" title="Fluconazole">fluconazole</a> available free of charge to governmental and <a href="/wiki/Non-governmental_organization" title="Non-governmental organization">non-governmental organizations</a> (NGOs) in <a href="/wiki/Developing_country" title="Developing country">developing countries</a> with a greater than 1% prevalence of <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV/AIDS</a>.<sup id="cite_ref-The_New_York_Times_178-0" class="reference"><a href="#cite_note-The_New_York_Times-178">[178]</a></sup><sup id="cite_ref-179" class="reference"><a href="#cite_note-179">[179]</a></sup><sup id="cite_ref-180" class="reference"><a href="#cite_note-180">[180]</a></sup> The company has also pledged to provide up to 740 million doses of its anti-<a href="/wiki/Pneumococcal_infection" title="Pneumococcal infection">pneumococcal</a> vaccine at discounted rates to infants and young children in 41 developing countries in association with the <a href="/wiki/GAVI_Alliance" class="mw-redirect" title="GAVI Alliance">GAVI Alliance</a>.<sup id="cite_ref-181" class="reference"><a href="#cite_note-181">[181]</a></sup></p><p>In 2012, Pfizer and the <a href="/wiki/Bill_%26_Melinda_Gates_Foundation" title="Bill &amp; Melinda Gates Foundation">Gates Foundation</a> announced a joint effort to provide affordable access to Pfizer's long-lasting injectable contraceptive, <a href="/wiki/Depot_medroxyprogesterone_acetate" class="mw-redirect" title="Depot medroxyprogesterone acetate">medroxyprogesterone acetate</a>, to three million women in developing countries.<sup id="cite_ref-182" class="reference"><a href="#cite_note-182">[182]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(12)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=36" title="Edit section: See also" data-section="36" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-12 collapsible-block" id="mf-section-12">
<style data-mw-deduplicate="TemplateStyles:r936637989">.mw-parser-output .portal{border:solid #aaa 1px;padding:0}.mw-parser-output .portal.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portal.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portal>ul{display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portal>ul>li{display:table-row}.mw-parser-output .portal>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portal>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}</style><div role="navigation" aria-label="Portals" class="noprint portal plainlist tright">
<ul><li><span><noscript><img alt="flag" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Flag_of_New_York_City.svg/32px-Flag_of_New_York_City.svg.png" decoding="async" width="32" height="19" class="noviewer thumbborder" data-file-width="500" data-file-height="300"></noscript><span class="lazy-image-placeholder" style="width: 32px;height: 19px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Flag_of_New_York_City.svg/32px-Flag_of_New_York_City.svg.png" data-alt="flag" data-width="32" data-height="19" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Flag_of_New_York_City.svg/48px-Flag_of_New_York_City.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Flag_of_New_York_City.svg/64px-Flag_of_New_York_City.svg.png 2x" data-class="noviewer thumbborder"> </span></span><span><a href="/wiki/Portal:New_York_City" title="Portal:New York City">New York City portal</a></span></li>
<li><span><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png" decoding="async" width="28" height="28" class="noviewer" data-file-width="512" data-file-height="512"></noscript><span class="lazy-image-placeholder" style="width: 28px;height: 28px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png" data-alt="" data-width="28" data-height="28" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/42px-Industry5.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/56px-Industry5.svg.png 2x" data-class="noviewer"> </span></span><span><a href="/wiki/Portal:Companies" title="Portal:Companies">Companies portal</a></span></li></ul></div>
<ul><li><a href="/wiki/Biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area" class="mw-redirect" title="Biotech and pharmaceutical companies in the New York metropolitan area">Biotech and pharmaceutical companies in the New York metropolitan area</a></li>
<li><a href="/wiki/Companies_of_the_United_States_with_untaxed_profits" title="Companies of the United States with untaxed profits">Companies of the United States with untaxed profits</a></li>
<li><a href="/wiki/Fire_in_the_Blood_(2013_film)" title="Fire in the Blood (2013 film)">Fire in the Blood (2013 film)</a></li>
<li><a href="/wiki/List_of_pharmaceutical_companies" title="List of pharmaceutical companies">List of pharmaceutical companies</a></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(13)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=37" title="Edit section: References" data-section="37" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-13 collapsible-block" id="mf-section-13">
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references"><li id="cite_note-pfizerFR2019-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-pfizerFR2019_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pfizerFR2019_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pfizerFR2019_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pfizerFR2019_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pfizerFR2019_1-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://s21.q4cdn.com/317678438/files/doc_financials/2018/ar/Pfizer-2019-Financial-Report.pdf">"Financial Review - Pfizer Inc. and Subsidiary Companies"</a> <span class="cs1-format">(PDF)</span>. Pfizer. 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">March 17,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Financial+Review+-+Pfizer+Inc.+and+Subsidiary+Companies&amp;rft.pub=Pfizer&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fs21.q4cdn.com%2F317678438%2Ffiles%2Fdoc_financials%2F2018%2Far%2FPfizer-2019-Financial-Report.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.pfizer.com/files/investors/financial_reports/annual_reports/2019/assets/pfizer-2019-annual-review.pdf">"Pfizer Annual Report 2019"</a> <span class="cs1-format">(PDF)</span>. Pfizer. 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Annual+Report+2019&amp;rft.pub=Pfizer&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Ffiles%2Finvestors%2Ffinancial_reports%2Fannual_reports%2F2019%2Fassets%2Fpfizer-2019-annual-review.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><cite id="CITEREFWells2008" class="citation">Wells, John C. (2008), <i>Longman Pronunciation Dictionary</i> (3rd ed.), Longman, <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9781405881180" title="Special:BookSources/9781405881180"><bdi>9781405881180</bdi></a></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Longman+Pronunciation+Dictionary&amp;rft.edition=3rd&amp;rft.pub=Longman&amp;rft.date=2008&amp;rft.isbn=9781405881180&amp;rft.aulast=Wells&amp;rft.aufirst=John+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-businessweek_2012-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-businessweek_2012_4-0">^</a></b></span> <span class="reference-text"><cite class="citation magazine"><a rel="nofollow" class="external text" href="http://www.businessweek.com/ap/2012-03/D9TP13I80.htm">"Pfizer moves higher amid persistent breakup talk"</a>. <i>Bloomberg Businessweek</i>. March 27, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">July 8,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=Pfizer+moves+higher+amid+persistent+breakup+talk&amp;rft.date=2012-03-27&amp;rft_id=http%3A%2F%2Fwww.businessweek.com%2Fap%2F2012-03%2FD9TP13I80.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Dow_Pfizer-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dow_Pfizer_5-0">^</a></b></span> <span class="reference-text"><cite class="citation"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20111030181836/http://stat1.moneycontrol.com/Dow_Jones_Industrial_Average_Historical_Components.pdf">"Dow Jones Industrial Average Historical Components"</a> <span class="cs1-format">(PDF)</span>, <i>moneycontrol.com</i>, archived from <a rel="nofollow" class="external text" href="http://stat1.moneycontrol.com/Dow_Jones_Industrial_Average_Historical_Components.pdf">the original</a> <span class="cs1-format">(PDF)</span> on October 30, 2011<span class="reference-accessdate">, retrieved <span class="nowrap">November 24,</span> 2015</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=moneycontrol.com&amp;rft.atitle=Dow+Jones+Industrial+Average+Historical+Components&amp;rft_id=http%3A%2F%2Fstat1.moneycontrol.com%2FDow_Jones_Industrial_Average_Historical_Components.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://fortune.com/fortune500/list/">"Fortune 500 Companies 2018: Who Made the List"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">November 10,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Fortune+500+Companies+2018%3A+Who+Made+the+List&amp;rft_id=http%3A%2F%2Ffortune.com%2Ffortune500%2Flist%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.bbc.co.uk/news/business-46616713">"<i>GlaxoSmithKline and Pfizer merge healthcare arms</i>"</a>. BBC. December 19, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">December 19,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=GlaxoSmithKline+and+Pfizer+merge+healthcare+arms&amp;rft.date=2018-12-19&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-46616713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/2015/11/24/us-allergan-m-a-pfizer-idUSKBN0TB0UT20151124">"Pfizer to buy Allergan in $160 billion deal"</a>. Reuters. November 24, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">November 26,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+to+buy+Allergan+in+%24160+billion+deal&amp;rft.date=2015-11-24&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2015%2F11%2F24%2Fus-allergan-m-a-pfizer-idUSKBN0TB0UT20151124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><cite class="citation news">Humer, Caroline; Banerjee, Ankur (April 6, 2016). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0X3188">"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change"</a>. <i>Reuters</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer%2C+Allergan+scrap+%24160+billion+deal+after+U.S.+tax+rule+change&amp;rft.date=2016-04-06&amp;rft.aulast=Humer&amp;rft.aufirst=Caroline&amp;rft.au=Banerjee%2C+Ankur&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-allergan-m-a-pfizer-idUSKCN0X3188&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Citycyclopedia-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Citycyclopedia_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Citycyclopedia_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Kenneth T. Jackson. <i>The Encyclopedia of New York City</i>. The New York Historical Society; Yale University Press; September 1995. P. 895. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-300-05536-8" title="Special:BookSources/978-0-300-05536-8">978-0-300-05536-8</a></span>
</li>
<li id="cite_note-Forbes-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Forbes_11-0">^</a></b></span> <span class="reference-text"><cite class="citation newsgroup"><a rel="nofollow" class="external text" href="https://www.forbes.com/sites/johnlamattina/2014/07/16/a-plan-for-big-pharma-involvement-in-superbug-rd/">"A Plan For Big Pharma Involvement In Superbug R&amp;D"</a>. July 16, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">August 9,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Plan+For+Big+Pharma+Involvement+In+Superbug+R%26D&amp;rft.date=2014-07-16&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fjohnlamattina%2F2014%2F07%2F16%2Fa-plan-for-big-pharma-involvement-in-superbug-rd%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/about/history/1951-1999">"Pfizer Inc: Exploring Our History 1951–1999"</a>. Pfizer.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Inc%3A+Exploring+Our+History+1951%E2%80%931999&amp;rft.pub=Pfizer&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fabout%2Fhistory%2F1951-1999&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://money.cnn.com/1999/07/19/companies/pfizer/">"Pfizer to pay $20M federal fine; posts 2Q results - Jul. 19, 1999"</a>. <i>money.cnn.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 28,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=money.cnn.com&amp;rft.atitle=Pfizer+to+pay+%2420M+federal+fine%3B+posts+2Q+results+-+Jul.+19%2C+1999&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F1999%2F07%2F19%2Fcompanies%2Fpfizer%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><cite id="CITEREFOldani2016" class="citation">Oldani, Michael (2016), <a rel="nofollow" class="external text" href="http://sk.sagepub.com/reference/the-sage-encyclopedia-of-pharmacology-and-society/i8915.xml">"Pfizer"</a>, <i>The SAGE Encyclopedia of Pharmacology and Society</i>, SAGE Publications, Inc., pp. 1063–1066, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4135%2F9781483349985.n303">10.4135/9781483349985.n303</a>, <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9781483350004" title="Special:BookSources/9781483350004"><bdi>9781483350004</bdi></a><span class="reference-accessdate">, retrieved <span class="nowrap">January 21,</span> 2019</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Pfizer&amp;rft.btitle=The+SAGE+Encyclopedia+of+Pharmacology+and+Society&amp;rft.pages=1063-1066&amp;rft.pub=SAGE+Publications%2C+Inc.&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.4135%2F9781483349985.n303&amp;rft.isbn=9781483350004&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fsk.sagepub.com%2Freference%2Fthe-sage-encyclopedia-of-pharmacology-and-society%2Fi8915.xml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-auto-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-auto_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-auto_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-auto_15-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Munos, Bernard. <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/bernardmunos/2015/11/30/pfizer-does-not-need-a-merger-it-needs-a-rebellion/#63d5153e21d6">"Pfizer Does Not Need A Merger, It Needs A Rebellion"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">May 23,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Does+Not+Need+A+Merger%2C+It+Needs+A+Rebellion&amp;rft.aulast=Munos&amp;rft.aufirst=Bernard&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fbernardmunos%2F2015%2F11%2F30%2Fpfizer-does-not-need-a-merger-it-needs-a-rebellion%2F%2363d5153e21d6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-investor_dec_2006-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-investor_dec_2006_16-0">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110505022552/http://www.investor.jnj.com/releasedetail.cfm?ReleaseID=223093">"Johnson &amp; Johnson Completes Acquisition Of Pfizer Consumer Healthcare"</a> (Press release). <a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a>. December 20, 2006. Archived from <a rel="nofollow" class="external text" href="http://www.investor.jnj.com/releaseDetail.cfm?releaseid=223093">the original</a> on May 5, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">July 12,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+Completes+Acquisition+Of+Pfizer+Consumer+Healthcare&amp;rft.pub=Johnson+%26+Johnson&amp;rft.date=2006-12-20&amp;rft_id=http%3A%2F%2Fwww.investor.jnj.com%2FreleaseDetail.cfm%3Freleaseid%3D223093&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-NYT_dec_2006-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-NYT_dec_2006_17-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Saul, Stephanie (June 27, 2006). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2006/06/27/business/johnson-johnson-buys-pfizer-unit-for-166-billion.html">"Johnson &amp; Johnson Buys Pfizer Unit for $16.6 billion"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">November 24,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Johnson+%26+Johnson+Buys+Pfizer+Unit+for+%2416.6+billion&amp;rft.date=2006-06-27&amp;rft.aulast=Saul&amp;rft.aufirst=Stephanie&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F06%2F27%2Fbusiness%2Fjohnson-johnson-buys-pfizer-unit-for-166-billion.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-NYT_2006-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-NYT_2006_18-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBerenson,_AlexPollack,_Andrew2006" class="citation">Berenson, Alex; Pollack, Andrew (December 5, 2006), <a rel="nofollow" class="external text" href="https://www.nytimes.com/2006/12/05/health/05pfizer.html?oref=slogin">"Pfizer Shares Plummet on Loss of a Promising Heart Drug"</a>, <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i><span class="reference-accessdate">, retrieved <span class="nowrap">November 24,</span> 2015</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Shares+Plummet+on+Loss+of+a+Promising+Heart+Drug&amp;rft.date=2006-12-05&amp;rft.au=Berenson%2C+Alex&amp;rft.au=Pollack%2C+Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F05%2Fhealth%2F05pfizer.html%3Foref%3Dslogin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Berenson_20061203-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-Berenson_20061203_19-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Berenson, Alex (December 3, 2006). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2006/12/03/health/03pfizer.html?_r=1&amp;th&amp;emc=th&amp;oref=slogin">"Pfizer Ends Studies on Drug for Heart Disease"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 3,</span> 2006</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Ends+Studies+on+Drug+for+Heart+Disease&amp;rft.date=2006-12-03&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F03%2Fhealth%2F03pfizer.html%3F_r%3D1%26th%26emc%3Dth%26oref%3Dslogin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation news">Theresa Agovino (December 3, 2006). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20061214175806/https://news.yahoo.com/s/ap/20061203/ap_on_he_me/pfizer_cholesterol_drug_5">"Pfizer ends cholesterol drug development"</a>. <i>Yahoo! News</i>. Associated Press. Archived from <a rel="nofollow" class="external text" href="https://news.yahoo.com/s/ap/20061203/ap_on_he_me/pfizer_cholesterol_drug_5">the original</a> on December 14, 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">December 3,</span> 2006</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Yahoo%21+News&amp;rft.atitle=Pfizer+ends+cholesterol+drug+development&amp;rft.date=2006-12-03&amp;rft.au=Theresa+Agovino&amp;rft_id=https%3A%2F%2Fnews.yahoo.com%2Fs%2Fap%2F20061203%2Fap_on_he_me%2Fpfizer_cholesterol_drug_5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><i>Each study arm (torcetrapib + Lipitor vs. Lipitor alone) had 7500 patients enrolled; 51 deaths were observed in the Lipitor alone arm, while 82 deaths occurred in the torcetrapib + Lipitor arm.</i></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation web">Barriaux, Marianne (October 9, 2006). <a rel="nofollow" class="external text" href="https://www.theguardian.com/business/2006/oct/09/money5">"Pfizer buys vaccine developer PowderMed"</a>. <i>the Guardian</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 9,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=the+Guardian&amp;rft.atitle=Pfizer+buys+vaccine+developer+PowderMed&amp;rft.date=2006-10-09&amp;rft.aulast=Barriaux&amp;rft.aufirst=Marianne&amp;rft_id=http%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2006%2Foct%2F09%2Fmoney5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/09/03/business/03health.html">"Pfizer pays $2.3 billion to settle marketing case"</a>, <i>The New York Times,</i> September 2, 2009.</span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite class="citation web">Bennett, Simeon (July 8, 2010). <a rel="nofollow" class="external text" href="http://www.businessweek.com/magazine/content/10_29/b4187021988297.htm">"Pfizer: Civil Suits for Drug Counterfeiters"</a>. <i>BusinessWeek</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BusinessWeek&amp;rft.atitle=Pfizer%3A+Civil+Suits+for+Drug+Counterfeiters&amp;rft.date=2010-07-08&amp;rft.aulast=Bennett&amp;rft.aufirst=Simeon&amp;rft_id=http%3A%2F%2Fwww.businessweek.com%2Fmagazine%2Fcontent%2F10_29%2Fb4187021988297.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.cbsnews.com/8301-500395_162-57582958/pfizer-to-sell-viagra-online-in-first-for-big-pharma-ap/">"Pfizer to sell Viagra online, in first for Big Pharma: AP"</a>. CBS News<span class="reference-accessdate">. Retrieved <span class="nowrap">May 6,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+sell+Viagra+online%2C+in+first+for+Big+Pharma%3A+AP&amp;rft.pub=CBS+News&amp;rft_id=http%3A%2F%2Fwww.cbsnews.com%2F8301-500395_162-57582958%2Fpfizer-to-sell-viagra-online-in-first-for-big-pharma-ap%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text">Pfizer, <a rel="nofollow" class="external text" href="http://www.pfizer.com/about/history/pfizer_warner_lambert.jsp">2000: Pfizer joins forces with Warner–Lambert</a>, accessed April 7, 2010</span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.businessinsider.com/here-are-the-7-biggest-mergers-of-all-time-2017-5/#6-warner-lambert-warms-up-to-pfizer-89-billion-2">"Here are the 7 biggest mergers of all time"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 12,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider&amp;rft.atitle=Here+are+the+7+biggest+mergers+of+all+time&amp;rft_id=http%3A%2F%2Fwww.businessinsider.com%2Fhere-are-the-7-biggest-mergers-of-all-time-2017-5%2F%236-warner-lambert-warms-up-to-pfizer-89-billion-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-PT2008-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-PT2008_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PT2008_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Staff (August 1, 2008). <a rel="nofollow" class="external text" href="http://www.pharmacytimes.com/publications/supplement/2008/supp_2008-08/supp_2008-08_006">"Greenstone LLC - A Successful Business Model"</a>. Pharmacy Times.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Greenstone+LLC+-+A+Successful+Business+Model&amp;rft.date=2008-08-01&amp;rft.au=Staff&amp;rft_id=http%3A%2F%2Fwww.pharmacytimes.com%2Fpublications%2Fsupplement%2F2008%2Fsupp_2008-08%2Fsupp_2008-08_006&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-urlPharmacia_to_Spin_Off_Monsanto_Stake,_Less_Than_2_Years_After_Firms_Merger_Wall_Street_Journal_28nov01-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlPharmacia_to_Spin_Off_Monsanto_Stake,_Less_Than_2_Years_After_Firms_Merger_Wall_Street_Journal_28nov01_28-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://archive.today/20130415082118/http://www.mindfully.org/Industry/Monsanto-Pharmacia-SpinOff.htm">"Pharmacia to spin-off Monsanto stake, less than 2 years after firms' merger"</a>. <i>Wall Street Journal</i>. mindfully.org. November 28, 2001. Archived from <a rel="nofollow" class="external text" href="http://www.mindfully.org/Industry/Monsanto-Pharmacia-SpinOff.htm">the original</a> on April 15, 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Pharmacia+to+spin-off+Monsanto+stake%2C+less+than+2+years+after+firms%27+merger&amp;rft.date=2001-11-28&amp;rft_id=http%3A%2F%2Fwww.mindfully.org%2FIndustry%2FMonsanto-Pharmacia-SpinOff.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/files/annualreport/2010/financial/financial2010.pdf">"Pfizer 2010 annual financial review, p 25"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+2010+annual+financial+review%2C+p+25.&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Ffiles%2Fannualreport%2F2010%2Ffinancial%2Ffinancial2010.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20100711122156/http://www.businessweek.com/news/2010-06-05/pfizer-drug-targets-gene-flaw-to-shrink-lung-tumors-update1-.html">"Pfizer Drug Targets Gene Flaw to Shrink Lung Tumors (Update1)"</a>. <i>Businessweek</i>. Archived from <a rel="nofollow" class="external text" href="http://www.businessweek.com/news/2010-06-05/pfizer-drug-targets-gene-flaw-to-shrink-lung-tumors-update1-.html">the original</a> on July 11, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Businessweek&amp;rft.atitle=Pfizer+Drug+Targets+Gene+Flaw+to+Shrink+Lung+Tumors+%28Update1%29&amp;rft_id=http%3A%2F%2Fwww.businessweek.com%2Fnews%2F2010-06-05%2Fpfizer-drug-targets-gene-flaw-to-shrink-lung-tumors-update1-.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><cite class="citation news">Hensley, Scott (June 29, 2006). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB115154467879893805">"Pfizer to Make Generic Version of Its Zoloft"</a>. <i>Wall Street Journal</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Pfizer+to+Make+Generic+Version+of+Its+Zoloft&amp;rft.date=2006-06-29&amp;rft.aulast=Hensley&amp;rft.aufirst=Scott&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB115154467879893805&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-urlPfizer_plant_in_Michigan_to_cut_275_-_FiercePharma-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlPfizer_plant_in_Michigan_to_cut_275_-_FiercePharma_32-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercepharma.com/story/pfizer-plant-michigan-cut-275/2008-07-15">"Pfizer plant in Michigan to cut 275 – FiercePharma"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+plant+in+Michigan+to+cut+275+%E2%80%93+FiercePharma&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Fpfizer-plant-michigan-cut-275%2F2008-07-15&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/01/26/business/26drug.html">Pfizer Agrees to Pay $68 billion for Rival Drug Maker Wyeth</a> By ANDREW ROSS SORKIN and DUFF WILSON. January 26, 2009. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i></span>
</li>
<li id="cite_note-PfizerWyeth-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-PfizerWyeth_34-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20091019062550/http://www.pfizer.com/investors/shareholder_services/wyeth_transaction.jsp">"Wyeth Transaction"</a>. Pfizer. Archived from <a rel="nofollow" class="external text" href="http://www.pfizer.com/investors/shareholder_services/wyeth_transaction.jsp">the original</a> on October 19, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">October 25,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Wyeth+Transaction&amp;rft.pub=Pfizer&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Finvestors%2Fshareholder_services%2Fwyeth_transaction.jsp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://industry.bnet.com/pharma/1000627/the-pfizer-wyeth-deal-worst-case-scenario/">The Pfizer–Wyeth Deal Worst-Case Scenario</a> By Jim Edwards | January 23, 2009 – BNET</span>
</li>
<li id="cite_note-Matthew-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-Matthew_36-0">^</a></b></span> <span class="reference-text">Matthew Karnitschnig, &amp; Jonathan D. Rockoff. (2009, January 23). Pfizer in Talks to Buy Wyeth. Wall Street Journal (Eastern Edition), p. A.1. Retrieved March 7, 2010, from Wall Street Journal. (Document ID: 1631280041).</span>
</li>
<li id="cite_note-htanna-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-htanna_37-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/idUSN1216434820101012">"Pfizer to buy King Pharma for $3.6 billion in cash"</a>. Reuters. October 12, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">October 12,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+to+buy+King+Pharma+for+%243.6+billion+in+cash&amp;rft.date=2010-10-12&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSN1216434820101012&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.bbc.co.uk/news/business-12335801">"Pfizer to close UK research site"</a>. <i>BBC News</i>. February 1, 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+close+UK+research+site&amp;rft.date=2011-02-01&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-12335801&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/research/science_and_technology/rd_locations/uk_sandwich">"Sandwich UK - Pfizer: One of the world's premier biopharmaceutical companies"</a>. <i>pfizer.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=pfizer.com&amp;rft.atitle=Sandwich+UK+-+Pfizer%3A+One+of+the+world%27s+premier+biopharmaceutical+companies&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fresearch%2Fscience_and_technology%2Frd_locations%2Fuk_sandwich&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/research/science_and_technology/rd_locations/uk_cambridge">"Cambridge, UK"</a>. <i>pfizer.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=pfizer.com&amp;rft.atitle=Cambridge%2C+UK&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fresearch%2Fscience_and_technology%2Frd_locations%2Fuk_cambridge&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/2012/09/04/us-pfizer-leukemia-idUSBRE88314720120904">"FDA approves Pfizer leukemia drug"</a>. <i>Reuters</i>. September 4, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">September 4,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=FDA+approves+Pfizer+leukemia+drug&amp;rft.date=2012-09-04&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2012%2F09%2F04%2Fus-pfizer-leukemia-idUSBRE88314720120904&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-to-acquire-innopharma-for-up-to-360m/81250112/?kwrd=pfizer%20acquire">"GEN - News Highlights:Pfizer to Acquire InnoPharma for Up to $360M"</a>. <i>GEN</i>. July 16, 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+-+News+Highlights%3APfizer+to+Acquire+InnoPharma+for+Up+to+%24360M&amp;rft.date=2014-07-16&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-to-acquire-innopharma-for-up-to-360m%2F81250112%2F%3Fkwrd%3Dpfizer%2520acquire&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-buys-redvax-boosting-vaccine-portfolio/81250760/">"GEN - News Highlights:Pfizer Buys Redvax, Boosting Vaccine Portfolio"</a>. <i>GEN</i>. January 5, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+-+News+Highlights%3APfizer+Buys+Redvax%2C+Boosting+Vaccine+Portfolio&amp;rft.date=2015-01-05&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-buys-redvax-boosting-vaccine-portfolio%2F81250760%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program/81251059/">"GEN - News Highlights:Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program"</a>. <i>GEN</i>. March 23, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+-+News+Highlights%3APfizer%2C+Lilly+to+Resume+Phase+III+Tanezumab+Clinical+Program&amp;rft.date=2015-03-23&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program%2F81251059%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-buys-two-gsk-meningitis-vaccines-for-130m/81251415/">"Pfizer Buys Two GSK Meningitis Vaccines for $130M"</a>. <i>GEN</i>. June 22, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Pfizer+Buys+Two+GSK+Meningitis+Vaccines+for+%24130M&amp;rft.date=2015-06-22&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-buys-two-gsk-meningitis-vaccines-for-130m%2F81251415%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-to-acquire-anacor-pharmaceuticals-for-5-2b/81252725/">"Pfizer to Acquire Anacor Pharmaceuticals for $5.2B"</a>. <i>GEN</i>. May 16, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Pfizer+to+Acquire+Anacor+Pharmaceuticals+for+%245.2B&amp;rft.date=2016-05-16&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-to-acquire-anacor-pharmaceuticals-for-5-2b%2F81252725%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-places-high-bid-of-40m-for-bind-therapeutics/81253009/">"Pfizer Places High Bid of $40M for BIND Therapeutics - GEN News Highlights - GEN"</a>. July 27, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Places+High+Bid+of+%2440M+for+BIND+Therapeutics+-+GEN+News+Highlights+-+GEN&amp;rft.date=2016-07-27&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-places-high-bid-of-40m-for-bind-therapeutics%2F81253009%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-acquires-bamboo-therapeutics-in-a-645m-deal/81253031/">"Pfizer Acquires Bamboo Therapeutics in a $645M Deal - GEN News Highlights - GEN"</a>. August 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Acquires+Bamboo+Therapeutics+in+a+%24645M+Deal+-+GEN+News+Highlights+-+GEN&amp;rft.date=2016-08&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-acquires-bamboo-therapeutics-in-a-645m-deal%2F81253031%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-to-acquire-medivation-for-14b/81253113/">"Pfizer to Acquire Medivation for $14B - GEN News Highlights - GEN"</a>. August 22, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+Acquire+Medivation+for+%2414B+-+GEN+News+Highlights+-+GEN&amp;rft.date=2016-08-22&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-to-acquire-medivation-for-14b%2F81253113%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.bbc.co.uk/news/business-37150531">"Pfizer to buy cancer drug firm Medivation for $14bn"</a>. <i>BBC News</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+buy+cancer+drug+firm+Medivation+for+%2414bn&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-37150531&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b/81253123/">"Pfizer Buys AstraZeneca Antibiotics for Up to $1.575B - GEN News Highlights - GEN"</a>. August 24, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Buys+AstraZeneca+Antibiotics+for+Up+to+%241.575B+-+GEN+News+Highlights+-+GEN&amp;rft.date=2016-08-24&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b%2F81253123%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercepharma.com/pharma/pfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy">"Pfizer grabs AZ antibiotics in $1.5B deal. Pre-split prep or just another sales-boosting buy? - FiercePharma"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+grabs+AZ+antibiotics+in+%241.5B+deal.+Pre-split+prep+or+just+another+sales-boosting+buy%3F+-+FiercePharma&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/oncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m/81253205">"OncoImmune Licenses ONC-392 to Pfizer for Up to $250M"</a>. News: Discovery &amp; Development. <i><a href="/wiki/Gen._Eng._Biotechnol._News" class="mw-redirect" title="Gen. Eng. Biotechnol. News">Genetic Engineering &amp; Biotechnology News</a></i>. October 15, 2016. p. 15<span class="reference-accessdate">. Retrieved <span class="nowrap">November 4,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=OncoImmune+Licenses+ONC-392+to+Pfizer+for+Up+to+%24250M&amp;rft.pages=15&amp;rft.date=2016-10-15&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Foncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m%2F81253205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/pfizer-buys-theracon-for-810-million/">"Pfizer Acquires Rare-Drug Company Therachon for $810 Million"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Pfizer+Acquires+Rare-Drug+Company+Therachon+for+%24810+Million&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fpfizer-buys-theracon-for-810-million%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-array-biopharma-m-a-pfizer-idUKKCN1TI15T">"Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma"</a>. <i>Reuters</i>. June 17, 2019 – via uk.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+makes+%2410.6+billion+cancer+bet+in+cash+deal+for+Array+Biopharma&amp;rft.date=2019-06-17&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-array-biopharma-m-a-pfizer-idUKKCN1TI15T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/article/2012-08-13/aJUGSJTj_ui0.html">"Zoetis™ Files IPO Registration Statement"</a>. <i><a href="/wiki/Bloomberg_L.P." title="Bloomberg L.P.">Bloomberg L.P.</a></i> New York. August 13, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">February 1,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Bloomberg+L.P.&amp;rft.atitle=Zoetis%E2%84%A2+Files+IPO+Registration+Statement&amp;rft.date=2012-08-13&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Farticle%2F2012-08-13%2FaJUGSJTj_ui0.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-NYTIPO-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYTIPO_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYTIPO_57-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">J. de la Merced, Michael (February 1, 2013). <a rel="nofollow" class="external text" href="https://dealbook.nytimes.com/2013/02/01/shares-of-zoetis-surge-on-debut/">"Shares of Zoetis Surge on Debut"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. New York<span class="reference-accessdate">. Retrieved <span class="nowrap">February 1,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Shares+of+Zoetis+Surge+on+Debut&amp;rft.date=2013-02-01&amp;rft.aulast=J.+de+la+Merced&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2013%2F02%2F01%2Fshares-of-zoetis-surge-on-debut%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-WSJIPO-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-WSJIPO_58-0">^</a></b></span> <span class="reference-text"><cite class="citation news">DIETERICH, CHRIS (January 31, 2013). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB10001424127887323701904578276530830057770?mod=googlenews_wsj">"Zoetis Raises $2.2 Billion in IPO - WSJ.com"</a>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>. New York<span class="reference-accessdate">. Retrieved <span class="nowrap">February 1,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Zoetis+Raises+%242.2+Billion+in+IPO+-+WSJ.com&amp;rft.date=2013-01-31&amp;rft.aulast=DIETERICH&amp;rft.aufirst=CHRIS&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424127887323701904578276530830057770%3Fmod%3Dgooglenews_wsj&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-CBSIPO-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-CBSIPO_59-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.cbsnews.com/8301-34227_162-57567222/shares-of-animal-health-company-zoetis-soar-in-ipo/">"Shares of animal health company Zoetis soar in IPO"</a>. <i><a href="/wiki/CBS_News" title="CBS News">CBS News</a></i>. New York. February 1, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">February 1,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Shares+of+animal+health+company+Zoetis+soar+in+IPO&amp;rft.date=2013-02-01&amp;rft_id=http%3A%2F%2Fwww.cbsnews.com%2F8301-34227_162-57567222%2Fshares-of-animal-health-company-zoetis-soar-in-ipo%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite class="citation news">Ben Hirschler (April 28, 2014). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/2014/04/28/us-astrazeneca-pfizer-idUSBREA3R0H520140428">"Pfizer chases AstraZeneca for potential $100 billion deal"</a>. <i>Reuters</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+chases+AstraZeneca+for+potential+%24100+billion+deal&amp;rft.date=2014-04-28&amp;rft.au=Ben+Hirschler&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2014%2F04%2F28%2Fus-astrazeneca-pfizer-idUSBREA3R0H520140428&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><cite class="citation magazine">Brozak, Steve. <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/stephenbrozak/2014/04/30/no-longer-king-of-the-north-pfizer-looks-to-recapture-crown/">"No Longer King Of The North, Pfizer Looks To Recapture Crown"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 30,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=No+Longer+King+Of+The+North%2C+Pfizer+Looks+To+Recapture+Crown&amp;rft.aulast=Brozak&amp;rft.aufirst=Steve&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fstephenbrozak%2F2014%2F04%2F30%2Fno-longer-king-of-the-north-pfizer-looks-to-recapture-crown%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.bbc.com/news/business-27309849"><i>Cameron and Miliband clash over Pfizer deal</i></a>, BBC News, May 7, 2014.</span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.bbc.com/news/business-27344465"><i>US politicians raise questions over Pfizer bid</i></a>, BBC News, May 9, 2014.</span>
</li>
<li id="cite_note-PfizerBid-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-PfizerBid_64-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20140520215930/http://www.londonmercury.com/index.php/sid/222128733/scat/0f440bf3fff89f01/ht/AstraZeneca-rejects-Pfizer-final-takeover-offer-triggers-major-drop-in-shares">"AstraZeneca rejects Pfizer 'final' takeover offer, triggers major drop in shares"</a>. London Mercury. Archived from <a rel="nofollow" class="external text" href="http://www.londonmercury.com/index.php/sid/222128733/scat/0f440bf3fff89f01/ht/AstraZeneca-rejects-Pfizer-final-takeover-offer-triggers-major-drop-in-shares">the original</a> on May 20, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">May 20,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=AstraZeneca+rejects+Pfizer+%27final%27+takeover+offer%2C+triggers+major+drop+in+shares&amp;rft_id=http%3A%2F%2Fwww.londonmercury.com%2Findex.php%2Fsid%2F222128733%2Fscat%2F0f440bf3fff89f01%2Fht%2FAstraZeneca-rejects-Pfizer-final-takeover-offer-triggers-major-drop-in-shares&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/2014/11/17/us-merck-pfizer-idUSKCN0J10LR20141117">Pfizer dampens Astra bid hopes with German Merck cancer deal</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>, 17 November 2014</span>
</li>
<li id="cite_note-nytimes.com-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-nytimes.com_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nytimes.com_66-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">David Gelles &amp; Katie Thomas. <a rel="nofollow" class="external text" href="https://dealbook.nytimes.com/2015/02/05/pfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash">"Pfizer Bets $15 Billion on New Class of Generic Drugs"</a>. <i>The New York Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Bets+%2415+Billion+on+New+Class+of+Generic+Drugs&amp;rft.au=David+Gelles&amp;rft.au=Katie+Thomas&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2015%2F02%2F05%2Fpfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/78003/000119312515037588/d866443d8k.htm">"8-K"</a>. <i>sec.gov</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=sec.gov&amp;rft.atitle=8-K&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F78003%2F000119312515037588%2Fd866443d8k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/news/press-release/press-release-detail/pfizer_to_acquire_hospira">"Pfizer to Acquire Hospira - Pfizer: One of the world's premier biopharmaceutical companies"</a>. <i>pfizer.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=pfizer.com&amp;rft.atitle=Pfizer+to+Acquire+Hospira+-+Pfizer%3A+One+of+the+world%27s+premier+biopharmaceutical+companies&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_to_acquire_hospira&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite class="citation web">Neilan, Catherine (February 5, 2015). <a rel="nofollow" class="external text" href="http://www.cityam.com/208788/pfizer-hospira-share-prices-soar-after-17bn-deal-announced">"Pfizer, Hospira share prices to soar after $17bn deal announced"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">May 23,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer%2C+Hospira+share+prices+to+soar+after+%2417bn+deal+announced&amp;rft.date=2015-02-05&amp;rft.aulast=Neilan&amp;rft.aufirst=Catherine&amp;rft_id=http%3A%2F%2Fwww.cityam.com%2F208788%2Fpfizer-hospira-share-prices-soar-after-17bn-deal-announced&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://articles.economictimes.indiatimes.com/2009-12-16/news/28457975_1_hospira-generic-injectable-supply-active-pharmaceutical-ingredients">"US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn"</a>. <i>The Economic Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Economic+Times&amp;rft.atitle=US-based+Hospira+to+buy+Orchid+Chemicals%27+injectables+biz+for+%24400+mn&amp;rft_id=http%3A%2F%2Farticles.economictimes.indiatimes.com%2F2009-12-16%2Fnews%2F28457975_1_hospira-generic-injectable-supply-active-pharmaceutical-ingredients&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-BBC_23_nov_2015-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-BBC_23_nov_2015_71-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.bbc.co.uk/news/business-34900344">"Pfizer seals $160bn Allergan deal to create drugs giant"</a>. <i>BBC News</i>. November 23, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">November 24,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+seals+%24160bn+Allergan+deal+to+create+drugs+giant&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-34900344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Genegnews_2015-72"><span class="mw-cite-backlink">^ <a href="#cite_ref-Genegnews_2015_72-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Genegnews_2015_72-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-to-acquire-allergan-for-160b/81252011/">"Pfizer to Acquire Allergan for $160B"</a>. <i>GEN</i>. November 23, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Pfizer+to+Acquire+Allergan+for+%24160B&amp;rft.date=2015-11-23&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-to-acquire-allergan-for-160b%2F81252011%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-bloomberg_22_Nov_2015-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-bloomberg_22_Nov_2015_73-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Cynthia Koons (November 22, 2015). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/articles/2015-11-22/pfizer-allergan-said-to-be-close-to-150-billion-merger">"Pfizer and Allergan to Combine With Joint Value of $160 Billion"</a>. <i>Bloomberg.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Bloomberg.com&amp;rft.atitle=Pfizer+and+Allergan+to+Combine+With+Joint+Value+of+%24160+Billion&amp;rft.date=2015-11-22&amp;rft.au=Cynthia+Koons&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-11-22%2Fpfizer-allergan-said-to-be-close-to-150-billion-merger&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-premier_2015-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-premier_2015_74-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://archive.today/20151123173226/http://www.premierbiopharmaleader.com/en/media/press-releases/pfizer-and-allergan-to-combine/">"Disclaimer - PremierBiopharmaLeader"</a>. <i>premierbiopharmaleader.com</i>. Archived from <a rel="nofollow" class="external text" href="http://www.premierbiopharmaleader.com/en/media/press-releases/pfizer-and-allergan-to-combine/">the original</a> on November 23, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=premierbiopharmaleader.com&amp;rft.atitle=Disclaimer+-+PremierBiopharmaLeader&amp;rft_id=http%3A%2F%2Fwww.premierbiopharmaleader.com%2Fen%2Fmedia%2Fpress-releases%2Fpfizer-and-allergan-to-combine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><cite class="citation web">Bray, Chad (April 6, 2016). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2016/04/07/business/dealbook/pfizer-allergan-merger.html?_r=0">"Pfizer and Allergan Call Off Merger After Tax-Rule Changes"</a>. <i>New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 6,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=New+York+Times&amp;rft.atitle=Pfizer+and+Allergan+Call+Off+Merger+After+Tax-Rule+Changes&amp;rft.date=2016-04-06&amp;rft.au=Bray%2C+Chad&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2016%2F04%2F07%2Fbusiness%2Fdealbook%2Fpfizer-allergan-merger.html%3F_r%3D0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_to_organize_for_future_growth-0">"Pfizer To Organize For Future Growth"</a> (Press release). Pfizer. July 11, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">February 10,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+To+Organize+For+Future+Growth&amp;rft.pub=Pfizer&amp;rft.date=2018-07-11&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_to_organize_for_future_growth-0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_reviewing_strategic_alternatives_for_consumer_healthcare_business">"Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business - Pfizer: One of the world's premier biopharmaceutical companies"</a>. <i>www.pfizer.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.pfizer.com&amp;rft.atitle=Pfizer+Reviewing+Strategic+Alternatives+for+Consumer+Healthcare+Business+-+Pfizer%3A+One+of+the+world%27s+premier+biopharmaceutical+companies&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_reviewing_strategic_alternatives_for_consumer_healthcare_business&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-pfizer-divestiture-exclusive-idUSKBN1CU2RW">"Exclusive: Pfizer to launch consumer health sale in November - sources"</a>. <i>Reuters</i>. October 26, 2017 – via www.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Exclusive%3A+Pfizer+to+launch+consumer+health+sale+in+November+-+sources&amp;rft.date=2017-10-26&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-divestiture-exclusive-idUSKBN1CU2RW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/reckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one">"Reckitt Benckiser's still keen on a Pfizer OTC buy. But can it afford one?"</a>. <i>FiercePharma</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Reckitt+Benckiser%27s+still+keen+on+a+Pfizer+OTC+buy.+But+can+it+afford+one%3F&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Freckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/glaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend">"GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?"</a>. <i>FiercePharma</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FiercePharma&amp;rft.atitle=GlaxoSmithKline+eyes+Pfizer%27s+OTC+unit.+But+will+a+buy+imperil+its+dividend%3F&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fglaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/sanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report">"Sanofi, J&amp;J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report"</a>. <i>FiercePharma</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Sanofi%2C+J%26J+could+join+GlaxoSmithKline%2C+Reckitt+in+%2420B+bidding+war+for+Pfizer+OTC%3A+report&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fsanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-pfizer-divestiture-glaxosmithkline-idUKKBN1GZ0WR">"GSK pulls out of $20 billion race for Pfizer consumer assets"</a>. <i>Reuters</i>. March 23, 2018 – via uk.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=GSK+pulls+out+of+%2420+billion+race+for+Pfizer+consumer+assets&amp;rft.date=2018-03-23&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-pfizer-divestiture-glaxosmithkline-idUKKBN1GZ0WR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture/">"GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture - GSK"</a>. <i>www.gsk.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.gsk.com&amp;rft.atitle=GlaxoSmithKline+plc+and+Pfizer+Inc+to+form+new+world-leading+Consumer+Healthcare+Joint+Venture+-+GSK&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fglaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company">"Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company - Pfizer: One of the world's premier biopharmaceutical companies"</a>. <i>www.pfizer.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.pfizer.com&amp;rft.atitle=Pfizer+and+GlaxoSmithKline+Announce+Joint+Venture+to+Create+a+Premier+Global+Consumer+Healthcare+Company+-+Pfizer%3A+One+of+the+world%27s+premier+biopharmaceutical+companies&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-mylan-nl-m-a-pfizer-idUKKCN1UM0DP">"Pfizer in talks to merge off-patent drugs business with Mylan: source"</a>. <i>Reuters</i>. July 27, 2019 – via uk.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+in+talks+to+merge+off-patent+drugs+business+with+Mylan%3A+source&amp;rft.date=2019-07-27&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-mylan-nl-m-a-pfizer-idUKKCN1UM0DP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/pfizer-merges-off-patent-upjohn-business-with-mylan/">"Mylan's Merger with Pfizer's Off-Patent Drug Unit Will Create 'New Champion for Global Health<span class="cs1-kern-right">'</span>"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Mylan%27s+Merger+with+Pfizer%27s+Off-Patent+Drug+Unit+Will+Create+%27New+Champion+for+Global+Health%27&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fpfizer-merges-off-patent-upjohn-business-with-mylan%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/uk-mylan-pfizer-idUKKCN1UO17H">"Pfizer to spinoff, merge off-patent drugs unit with Mylan"</a>. <i>Reuters</i>. July 29, 2019 – via uk.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+spinoff%2C+merge+off-patent+drugs+unit+with+Mylan&amp;rft.date=2019-07-29&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fuk-mylan-pfizer-idUKKCN1UO17H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-leadstruc-88"><span class="mw-cite-backlink">^ <a href="#cite_ref-leadstruc_88-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-leadstruc_88-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/about/leadership_and_structure/leadership_structure.jsp">"Pfizer Leadership and Structure"</a>. Pfizer<span class="reference-accessdate">. Retrieved <span class="nowrap">January 6,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Leadership+and+Structure&amp;rft.pub=Pfizer&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fabout%2Fleadership_and_structure%2Fleadership_structure.jsp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation news">Gali, Weinreb (May 14, 2015). <a rel="nofollow" class="external text" href="http://www.globes.co.il/en/article-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703">"Pfizer to collaborate on Bar-Ilan DNA robots"</a>. <i><a href="/wiki/Globes" title="Globes">Globes</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 6,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Globes&amp;rft.atitle=Pfizer+to+collaborate+on+Bar-Ilan+DNA+robots&amp;rft.date=2015-05-14&amp;rft.aulast=Gali&amp;rft.aufirst=Weinreb&amp;rft_id=http%3A%2F%2Fwww.globes.co.il%2Fen%2Farticle-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/investors/financial_reports/financial_reports_annualreview_2007.jsp">"Annual Review 2007 | Pfizer: the world's largest research-based pharmaceutical company"</a>. Pfizer. October 9, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Annual+Review+2007+%26%23124%3B+Pfizer%3A+the+world%27s+largest+research-based+pharmaceutical+company&amp;rft.pub=Pfizer&amp;rft.date=2009-10-09&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Finvestors%2Ffinancial_reports%2Ffinancial_reports_annualreview_2007.jsp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><cite class="citation news">Pollack, Andrew (September 2, 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/09/02/health/research/02cancerdrug.html">"For Profit, Industry Seeks Cancer Drugs"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 3,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=For+Profit%2C+Industry+Seeks+Cancer+Drugs&amp;rft.date=2009-09-02&amp;rft.au=Pollack%2C+Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F02%2Fhealth%2Fresearch%2F02cancerdrug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.mlive.com/business/kzgazette/index.ssf?/base/business-3/116957280214420.xml&amp;coll=7">Pfizer's cuts blindside Ann Arbor workers</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20070927194206/http://www.mlive.com/business/kzgazette/index.ssf?%2Fbase%2Fbusiness-3%2F116957280214420.xml&amp;coll=7">Archived</a> September 27, 2007, at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>, Kalamazoo Gazette, Sunday, January 23, 2007.</span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.wwmt.com/news/kalamazoo_36503___article.html/research_pfizer.html">Pfizer Reorganization Could Bring Jobs To Kalamazoo</a>, WWMT.com, June 18, 2007 <a rel="nofollow" class="external text" href="https://web.archive.org/web/20131021192405/http://www.wwmt.com/news/kalamazoo_36503___article.html/research_pfizer.html">Archived</a> 21 October 2013 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120610052548/http://www.kentonline.co.uk/kentonline/news/2011/february/1/drug_giant_to_pull_out_of_kent.aspx">"Drug giant Pfizer to pull out of Kent"</a>. Kentonline.co.uk. February 1, 2011. Archived from <a rel="nofollow" class="external text" href="http://www.kentonline.co.uk/kentonline/news/2011/february/1/drug_giant_to_pull_out_of_kent.aspx">the original</a> on June 10, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drug+giant+Pfizer+to+pull+out+of+Kent&amp;rft.pub=Kentonline.co.uk&amp;rft.date=2011-02-01&amp;rft_id=http%3A%2F%2Fwww.kentonline.co.uk%2Fkentonline%2Fnews%2F2011%2Ffebruary%2F1%2Fdrug_giant_to_pull_out_of_kent.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.bbc.co.uk/news/uk-england-kent-15584902">"Pfizer site in Sandwich set to retain 650 jobs"</a>. <i>BBC News</i>. November 4, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">July 9,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+site+in+Sandwich+set+to+retain+650+jobs&amp;rft.date=2011-11-04&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fuk-england-kent-15584902&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://web.mit.edu/newsoffice/2011/pfizer-mit-610-main.html">"Pfizer Expands its Research Footprint in Cambridge"</a>. MITnews. September 1, 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Expands+its+Research+Footprint+in+Cambridge&amp;rft.pub=MITnews&amp;rft.date=2011-09-01&amp;rft_id=http%3A%2F%2Fweb.mit.edu%2Fnewsoffice%2F2011%2Fpfizer-mit-610-main.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Hiltzik-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hiltzik_97-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFHiltzik2018" class="citation"><a href="/wiki/Michael_Hiltzik" title="Michael Hiltzik">Hiltzik, Michael</a> (January 8, 2018), <a rel="nofollow" class="external text" href="https://www.latimes.com/business/hiltzik/la-fi-hiltzik-pfizer-20180108-story.html">"Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer's and Parkinson's research"</a>, <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i><span class="reference-accessdate">, retrieved <span class="nowrap">January 27,</span> 2018</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Pfizer%2C+pocketing+a+big+tax+cut+from+Trump%2C+will+end+investment+in+Alzheimer%27s+and+Parkinson%27s+research&amp;rft.date=2018-01-08&amp;rft.aulast=Hiltzik&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Fbusiness%2Fhiltzik%2Fla-fi-hiltzik-pfizer-20180108-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><cite class="citation web">Speights, Keith (April 17, 2017). <a rel="nofollow" class="external text" href="https://www.fool.com/investing/2017/04/17/how-pfizer-inc-makes-most-of-its-money.aspx">"How Pfizer Inc. Makes Most of Its Money -"</a>. <i>The Motley Fool</i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Motley+Fool&amp;rft.atitle=How+Pfizer+Inc.+Makes+Most+of+Its+Money+-&amp;rft.date=2017-04-17&amp;rft.aulast=Speights&amp;rft.aufirst=Keith&amp;rft_id=https%3A%2F%2Fwww.fool.com%2Finvesting%2F2017%2F04%2F17%2Fhow-pfizer-inc-makes-most-of-its-money.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-cdc.gov-99"><span class="mw-cite-backlink">^ <a href="#cite_ref-cdc.gov_99-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cdc.gov_99-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.cdc.gov/abcs/reports-findings/surv-reports.html">"CDC - ABCs: Surveillance Reports main page - Active Bacterial Core surveillance"</a>. April 5, 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CDC+-+ABCs%3A+Surveillance+Reports+main+page+-+Active+Bacterial+Core+surveillance&amp;rft.date=2019-04-05&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fabcs%2Freports-findings%2Fsurv-reports.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text">Susan Decker for Bloomberg News. Feb 6, 2014. <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2014-02-06/pfizer-wins-ruling-to-block-generic-lyrica-until-2018.html">Pfizer Wins Ruling to Block Generic Lyrica Until 2018</a></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/postmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns">"Pfizer switches RA patients to lower dose of fast-growing Xeljanz as safety issues arise in postmarketing study"</a>. <i>FiercePharma</i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+switches+RA+patients+to+lower+dose+of+fast-growing+Xeljanz+as+safety+issues+arise+in+postmarketing+study&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpostmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text">Hollis, Liz <a rel="nofollow" class="external text" href="http://www.fiercepharma.com/special-reports/top-10-generic-drug-companies-2010/greenstone-top-10-generic-drug-companies-2010">"Greenstone – Top 10 Generic Drug Companies 2010"</a> Fierce Pharma, August 10, 2010</span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><cite class="citation web">Original Compilation (February 28, 2019). <a rel="nofollow" class="external text" href="https://fintel.io/doc/sec/78003/000007800319000015/pfe-exhibit21x12312018x10k.htm">"PFE / Pfizer, Inc. SUBSIDIARIES OF THE COMPANY - Fintel.io"</a>. <i>fintel.io</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 12,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=fintel.io&amp;rft.atitle=PFE+%2F+Pfizer%2C+Inc.+SUBSIDIARIES+OF+THE+COMPANY+-+Fintel.io&amp;rft.date=2019-02-28&amp;rft.au=Original+Compilation&amp;rft_id=https%3A%2F%2Ffintel.io%2Fdoc%2Fsec%2F78003%2F000007800319000015%2Fpfe-exhibit21x12312018x10k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-FDA_Lipitor-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA_Lipitor_104-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails">"List of US FDA Approved Drugs"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">April 12,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=List+of+US+FDA+Approved+Drugs&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fdrugsatfda%2Findex.cfm%3Ffuseaction%3DSearch.DrugDetails&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-url_Crain_2011-105"><span class="mw-cite-backlink">^ <a href="#cite_ref-url_Crain_2011_105-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-url_Crain_2011_105-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.crainsnewyork.com/article/20111228/HEALTH_CARE/111229902">"Lipitor becomes world's top-selling drug"</a>. Crain's New York Business via Associated Press. December 28, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">November 24,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lipitor+becomes+world%27s+top-selling+drug&amp;rft.pub=Crain%27s+New+York+Business+via+Associated+Press&amp;rft.date=2011-12-28&amp;rft_id=http%3A%2F%2Fwww.crainsnewyork.com%2Farticle%2F20111228%2FHEALTH_CARE%2F111229902&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-CNN_Wire_Staff-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-CNN_Wire_Staff_106-0">^</a></b></span> <span class="reference-text"><cite class="citation news">CNN Wire Staff (November 30, 2011). <a rel="nofollow" class="external text" href="http://edition.cnn.com/2011/11/30/health/lipitor-generic/index.html">"Lipitor loses patent, goes generic"</a>. CNN<span class="reference-accessdate">. Retrieved <span class="nowrap">November 18,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lipitor+loses+patent%2C+goes+generic&amp;rft.date=2011-11-30&amp;rft.au=CNN+Wire+Staff&amp;rft_id=http%3A%2F%2Fedition.cnn.com%2F2011%2F11%2F30%2Fhealth%2Flipitor-generic%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><cite class="citation journal">Charlier C, Hart E, Lefort A,  et al. (March 2006). "Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?". <i>J. Antimicrob. Chemother</i>. <b>57</b> (3): 384–410. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjac%2Fdki473">10.1093/jac/dki473</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16449304">16449304</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Antimicrob.+Chemother.&amp;rft.atitle=Fluconazole+for+the+management+of+invasive+candidiasis%3A+where+do+we+stand+after+15+years%3F&amp;rft.volume=57&amp;rft.issue=3&amp;rft.pages=384-410&amp;rft.date=2006-03&amp;rft_id=info%3Adoi%2F10.1093%2Fjac%2Fdki473&amp;rft_id=info%3Apmid%2F16449304&amp;rft.aulast=Charlier&amp;rft.aufirst=C&amp;rft.au=Hart%2C+E&amp;rft.au=Lefort%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><cite class="citation journal">Blyth CC, Barzi F, Hale K, Isaacs D (September 2012). "Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin". <i>J Paediatr Child Health</i>. <b>48</b> (9): 846–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1440-1754.2012.02543.x">10.1111/j.1440-1754.2012.02543.x</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22970680">22970680</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Paediatr+Child+Health&amp;rft.atitle=Chemoprophylaxis+of+neonatal+fungal+infections+in+very+low+birthweight+infants%3A+efficacy+and+safety+of+fluconazole+and+nystatin&amp;rft.volume=48&amp;rft.issue=9&amp;rft.pages=846-51&amp;rft.date=2012-09&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1440-1754.2012.02543.x&amp;rft_id=info%3Apmid%2F22970680&amp;rft.aulast=Blyth&amp;rft.aufirst=CC&amp;rft.au=Barzi%2C+F&amp;rft.au=Hale%2C+K&amp;rft.au=Isaacs%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-World_Health_Organization-109"><span class="mw-cite-backlink">^ <a href="#cite_ref-World_Health_Organization_109-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-World_Health_Organization_109-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-World_Health_Organization_109-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1">"WHO Model List of EssentialMedicines"</a> <span class="cs1-format">(PDF)</span>. <i>World Health Organization</i>. October 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">April 22,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization&amp;rft.atitle=WHO+Model+List+of+EssentialMedicines&amp;rft.date=2013-10&amp;rft_id=http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2F10665%2F93142%2F1%2FEML_18_eng.pdf%3Fua%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://khn.org/morning-breakout/dr00005040/">"Pfizer to Expand Fluconazole Donation Program to More than 50 Developing Nations"</a>. <i>Kaiser Health News</i>. June 7, 2001<span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Kaiser+Health+News&amp;rft.atitle=Pfizer+to+Expand+Fluconazole+Donation+Program+to+More+than+50+Developing+Nations&amp;rft.date=2001-06-07&amp;rft_id=https%3A%2F%2Fkhn.org%2Fmorning-breakout%2Fdr00005040%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-monograph-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-monograph_111-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/metronidazole.html">"Metronidazole Monograph for Professionals"</a>. drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">April 3,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Metronidazole+Monograph+for+Professionals&amp;rft.pub=drugs.com&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fmetronidazole.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><cite class="citation journal">Cohen, S. H.; Gerding, D. N.; Johnson, S.; Kelly, C. P.; Loo, V. G.; McDonald, L. C.; Pepin, J.; Wilcox, M. H.; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America (2010). "Clinical Practice Guidelines for <i>Clostridium difficile</i> Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)". <i>Infection Control and Hospital Epidemiology</i>. <b>31</b> (5): 431–455. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1086%2F651706">10.1086/651706</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20307191">20307191</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infection+Control+and+Hospital+Epidemiology&amp;rft.atitle=Clinical+Practice+Guidelines+for+Clostridium+difficile+Infection+in+Adults%3A+2010+Update+by+the+Society+for+Healthcare+Epidemiology+of+America+%28SHEA%29+and+the+Infectious+Diseases+Society+of+America+%28IDSA%29&amp;rft.volume=31&amp;rft.issue=5&amp;rft.pages=431-455&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1086%2F651706&amp;rft_id=info%3Apmid%2F20307191&amp;rft.aulast=Cohen&amp;rft.aufirst=S.+H.&amp;rft.au=Gerding%2C+D.+N.&amp;rft.au=Johnson%2C+S.&amp;rft.au=Kelly%2C+C.+P.&amp;rft.au=Loo%2C+V.+G.&amp;rft.au=McDonald%2C+L.+C.&amp;rft.au=Pepin%2C+J.&amp;rft.au=Wilcox%2C+M.+H.&amp;rft.au=Society+for+Healthcare+Epidemiology+of+America&amp;rft.au=Infectious+Diseases+Society+of+America&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><cite class="citation journal">Dickson, Sean (February 25, 2019). "Effect of Evergreened Reformulations on Medicaid Expenditures and Patient Access from 2008 to 2016". <i>Journal of Managed Care &amp; Specialty Pharmacy</i>. <b>25</b> (7): 780–792. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.18553%2Fjmcp.2019.18366">10.18553/jmcp.2019.18366</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2376-0540">2376-0540</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30799664">30799664</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Managed+Care+%26+Specialty+Pharmacy&amp;rft.atitle=Effect+of+Evergreened+Reformulations+on+Medicaid+Expenditures+and+Patient+Access+from+2008+to+2016&amp;rft.volume=25&amp;rft.issue=7&amp;rft.pages=780-792&amp;rft.date=2019-02-25&amp;rft.issn=2376-0540&amp;rft_id=info%3Apmid%2F30799664&amp;rft_id=info%3Adoi%2F10.18553%2Fjmcp.2019.18366&amp;rft.aulast=Dickson&amp;rft.aufirst=Sean&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><cite class="citation news">Kennedy VB (22 March 2007). <a rel="nofollow" class="external text" href="http://www.marketwatch.com/news/story/pfizer-loses-court-ruling-norvasc/story.aspx?guid=%7B9819D67E-B76B-431D-835C-FB8D6D8327B7%7D">"Pfizer loses court ruling on Norvasc patent"</a>. <i>MarketWatch</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20080803060500/http://www.marketwatch.com/news/story/pfizer-loses-court-ruling-norvasc/story.aspx?guid=%7B9819D67E-B76B-431D-835C-FB8D6D8327B7%7D">Archived</a> from the original on 3 August 2008.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MarketWatch&amp;rft.atitle=Pfizer+loses+court+ruling+on+Norvasc+patent&amp;rft.date=2007-03-22&amp;rft.au=Kennedy+VB&amp;rft_id=http%3A%2F%2Fwww.marketwatch.com%2Fnews%2Fstory%2Fpfizer-loses-court-ruling-norvasc%2Fstory.aspx%3Fguid%3D%257B9819D67E-B76B-431D-835C-FB8D6D8327B7%257D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><cite class="citation journal">Mandell LA, Wunderink RG, Anzueto A,  et al. (March 2007). <a rel="nofollow" class="external text" href="https://www.thoracic.org/statements/resources/mtpi/idsaats-cap.pdf">"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults"</a> <span class="cs1-format">(PDF)</span>. <i>Clin. Infect. Dis</i>. 44 Suppl 2: S27–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1086%2F511159">10.1086/511159</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7107997">7107997</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17278083">17278083</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Infect.+Dis.&amp;rft.atitle=Infectious+Diseases+Society+of+America%2FAmerican+Thoracic+Society+consensus+guidelines+on+the+management+of+community-acquired+pneumonia+in+adults&amp;rft.volume=44+Suppl+2&amp;rft.pages=S27-72&amp;rft.date=2007-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7107997&amp;rft_id=info%3Apmid%2F17278083&amp;rft_id=info%3Adoi%2F10.1086%2F511159&amp;rft.aulast=Mandell&amp;rft.aufirst=LA&amp;rft.au=Wunderink%2C+RG&amp;rft.au=Anzueto%2C+A&amp;rft_id=https%3A%2F%2Fwww.thoracic.org%2Fstatements%2Fresources%2Fmtpi%2Fidsaats-cap.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.wipo.int/ipadvantage/en/details.jsp?id=906">"Azithromycin: A world best-selling Antibiotic"</a>. <i>www.wipo.int</i>. World Intellectual Property Organization<span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.wipo.int&amp;rft.atitle=Azithromycin%3A+A+world+best-selling+Antibiotic&amp;rft_id=https%3A%2F%2Fwww.wipo.int%2Fipadvantage%2Fen%2Fdetails.jsp%3Fid%3D906&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><cite class="citation web">John M. Grohol (2012). <a rel="nofollow" class="external text" href="http://psychcentral.com/lib/2012/top-25-psychiatric-medication-prescriptions-for-2011/">"Top 25 Psychiatric Medication Prescriptions for 2011"</a>. Psych Central<span class="reference-accessdate">. Retrieved <span class="nowrap">January 9,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Top+25+Psychiatric+Medication+Prescriptions+for+2011&amp;rft.pub=Psych+Central&amp;rft.date=2012&amp;rft.au=John+M.+Grohol&amp;rft_id=http%3A%2F%2Fpsychcentral.com%2Flib%2F2012%2Ftop-25-psychiatric-medication-prescriptions-for-2011%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><cite class="citation web">Smith A (July 17, 2006). <a rel="nofollow" class="external text" href="http://money.cnn.com/2006/07/17/news/companies/pfizer/index.htm">"Pfizer needs more drugs"</a>. <a href="/wiki/CNN.com" class="mw-redirect" title="CNN.com">CNNMoney.com</a><span class="reference-accessdate">. Retrieved <span class="nowrap">January 27,</span> 2007</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+needs+more+drugs&amp;rft.pub=CNNMoney.com&amp;rft.date=2006-07-17&amp;rft.aulast=Smith&amp;rft.aufirst=Aaron&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F2006%2F07%2F17%2Fnews%2Fcompanies%2Fpfizer%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><cite class="citation web">Kirkpatrick, By David D. <a rel="nofollow" class="external text" href="https://nymag.com/nymetro/health/features/3122/">"Inside the Happiness Business"</a>. <i>NYMag.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 21,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NYMag.com&amp;rft.atitle=Inside+the+Happiness+Business&amp;rft.aulast=Kirkpatrick&amp;rft.aufirst=By+David+D.&amp;rft_id=https%3A%2F%2Fnymag.com%2Fnymetro%2Fhealth%2Ffeatures%2F3122%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><cite class="citation journal">Oldani, Michael (2002). <a rel="nofollow" class="external text" href="http://digitalassets.lib.berkeley.edu/anthpubs/ucb/text/kas087-006.pdf">"Tales from the Script"</a> <span class="cs1-format">(PDF)</span>. <i>Kroeber Society Papers</i>. <b>87</b>: 147–176 – via University of California Berkeley.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kroeber+Society+Papers&amp;rft.atitle=Tales+from+the+Script&amp;rft.volume=87&amp;rft.pages=147-176&amp;rft.date=2002&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fdigitalassets.lib.berkeley.edu%2Fanthpubs%2Fucb%2Ftext%2Fkas087-006.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><cite class="citation journal">Oldani, Michael J. (2004). "Thick Prescriptions: Toward an Interpretation of Pharmaceutical Sales Practices". <i>Medical Anthropology Quarterly</i>. <b>18</b> (3): 325–356. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1525%2Fmaq.2004.18.3.325">10.1525/maq.2004.18.3.325</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1548-1387">1548-1387</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15484967">15484967</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Anthropology+Quarterly&amp;rft.atitle=Thick+Prescriptions%3A+Toward+an+Interpretation+of+Pharmaceutical+Sales+Practices&amp;rft.volume=18&amp;rft.issue=3&amp;rft.pages=325-356&amp;rft.date=2004&amp;rft.issn=1548-1387&amp;rft_id=info%3Apmid%2F15484967&amp;rft_id=info%3Adoi%2F10.1525%2Fmaq.2004.18.3.325&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><cite class="citation journal">Steinman MA, Bero LA, Chren MM, Landefeld CS (August 2006). "Narrative review: the promotion of gabapentin: an analysis of internal industry documents". <i><a href="/wiki/Annals_of_Internal_Medicine" title="Annals of Internal Medicine">Ann. Intern. Med.</a></i> <b>145</b> (4): 284–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-145-4-200608150-00008">10.7326/0003-4819-145-4-200608150-00008</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16908919">16908919</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.atitle=Narrative+review%3A+the+promotion+of+gabapentin%3A+an+analysis+of+internal+industry+documents&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=284-93&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00008&amp;rft_id=info%3Apmid%2F16908919&amp;rft.aulast=Steinman&amp;rft.aufirst=MA&amp;rft.au=Bero%2C+LA&amp;rft.au=Chren%2C+MM&amp;rft.au=Landefeld%2C+CS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text">The settlement was the first <a href="/wiki/List_of_off-label_promotion_pharmaceutical_settlements" title="List of off-label promotion pharmaceutical settlements">off-label promotion case</a> successfully brought under the False Claims Act.
<cite class="citation journal">Henney JE (August 2006). "Safeguarding patient welfare: who's in charge?". <i><a href="/wiki/Annals_of_Internal_Medicine" title="Annals of Internal Medicine">Ann. Intern. Med.</a></i> <b>145</b> (4): 305–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-145-4-200608150-00013">10.7326/0003-4819-145-4-200608150-00013</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16908923">16908923</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.atitle=Safeguarding+patient+welfare%3A+who%27s+in+charge%3F&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=305-7&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00013&amp;rft_id=info%3Apmid%2F16908923&amp;rft.au=Henney+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text">
<cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm">"Warner–Lambert to pay $430 million to resolve criminal &amp; civil health care liability relating to off-label promotion"</a> (Press release). <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">US Department of Justice</a>. May 13, 2004<span class="reference-accessdate">. Retrieved <span class="nowrap">December 2,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Warner%E2%80%93Lambert+to+pay+%24430+million+to+resolve+criminal+%26+civil+health+care+liability+relating+to+off-label+promotion&amp;rft.pub=US+Department+of+Justice&amp;rft.date=2004-05-13&amp;rft_id=http%3A%2F%2Fwww.usdoj.gov%2Fopa%2Fpr%2F2004%2FMay%2F04_civ_322.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><cite class="citation journal">Mulleners WM, McCrory DC, Linde M (August 2014). "Antiepileptics in migraine prophylaxis: An updated Cochrane review". <i>Cephalalgia</i>. <b>35</b> (1): 51–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F0333102414534325">10.1177/0333102414534325</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25115844">25115844</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cephalalgia&amp;rft.atitle=Antiepileptics+in+migraine+prophylaxis%3A+An+updated+Cochrane+review&amp;rft.volume=35&amp;rft.issue=1&amp;rft.pages=51-62&amp;rft.date=2014-08&amp;rft_id=info%3Adoi%2F10.1177%2F0333102414534325&amp;rft_id=info%3Apmid%2F25115844&amp;rft.aulast=Mulleners&amp;rft.aufirst=WM&amp;rft.au=McCrory%2C+DC&amp;rft.au=Linde%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><cite class="citation journal">Loder E, Burch R, Rizzoli P (June 2012). "The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines". <i>Headache</i>. <b>52</b> (6): 930–45. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x">10.1111/j.1526-4610.2012.02185.x</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22671714">22671714</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Headache&amp;rft.atitle=The+2012+AHS%2FAAN+guidelines+for+prevention+of+episodic+migraine%3A+a+summary+and+comparison+with+other+recent+clinical+practice+guidelines&amp;rft.volume=52&amp;rft.issue=6&amp;rft.pages=930-45&amp;rft.date=2012-06&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1526-4610.2012.02185.x&amp;rft_id=info%3Apmid%2F22671714&amp;rft.aulast=Loder&amp;rft.aufirst=E&amp;rft.au=Burch%2C+R&amp;rft.au=Rizzoli%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-2.3_nytimes-127"><span class="mw-cite-backlink">^ <a href="#cite_ref-2.3_nytimes_127-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-2.3_nytimes_127-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Harris, Gardiner (September 3, 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/09/03/business/03health.html">"Pfizer Pays $2.3 billion to Settle Marketing Case"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Pays+%242.3+billion+to+Settle+Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F03%2Fbusiness%2F03health.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-wapo_offlabel-128"><span class="mw-cite-backlink">^ <a href="#cite_ref-wapo_offlabel_128-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-wapo_offlabel_128-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Johnson, Carrie (September 3, 2009). <a rel="nofollow" class="external text" href="https://www.washingtonpost.com/wp-dyn/content/article/2009/09/02/AR2009090201449_pf.html">"In Settlement, A Warning To Drugmakers: Pfizer to Pay Record Penalty In Improper-Marketing Case"</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=In+Settlement%2C+A+Warning+To+Drugmakers%3A+Pfizer+to+Pay+Record+Penalty+In+Improper-Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Johnson&amp;rft.aufirst=Carrie&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2009%2F09%2F02%2FAR2009090201449_pf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Pfizer_agrees_record_fraud_fine-129"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pfizer_agrees_record_fraud_fine_129-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pfizer_agrees_record_fraud_fine_129-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://news.bbc.co.uk/2/hi/business/8234533.stm">"Pfizer agrees record fraud fine"</a>. BBC. September 2, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">May 22,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+agrees+record+fraud+fine&amp;rft.date=2009-09-02&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F8234533.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://wayback.archive-it.org/all/20100301065703/http://www.justice.gov/usao/ma/Press%20Office%20-%20Press%20Release%20Files/Sept2009/PharmaciaPlea.html">"The United States Department of Justice – United States Attorney's Office – District of Massachusetts"</a>. Archived from <a rel="nofollow" class="external text" href="https://www.justice.gov/usao/ma/Press%20Office%20-%20Press%20Release%20Files/Sept2009/PharmaciaPlea.html">the original</a> on March 1, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+United+States+Department+of+Justice+%E2%80%93+United+States+Attorney%27s+Office+%E2%80%93+District+of+Massachusetts&amp;rft_id=http%3A%2F%2Fwww.justice.gov%2Fusao%2Fma%2FPress%2520Office%2520-%2520Press%2520Release%2520Files%2FSept2009%2FPharmaciaPlea.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110715112330/http://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf">"Corporate Integrity Agreement between the Office of the Inspector General of the Department of Health and Human Services and Pfizer Inc"</a> <span class="cs1-format">(PDF)</span>. <i>Office of Inspector General</i>. Archived from <a rel="nofollow" class="external text" href="https://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf">the original</a> <span class="cs1-format">(PDF)</span> on July 15, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">November 27,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+Inspector+General&amp;rft.atitle=Corporate+Integrity+Agreement+between+the+Office+of+the+Inspector+General+of+the+Department+of+Health+and+Human+Services+and+Pfizer+Inc.&amp;rft_id=http%3A%2F%2Foig.hhs.gov%2Ffraud%2Fcia%2Fagreements%2Fpfizer_inc.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Edwards-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-Edwards_132-0">^</a></b></span> <span class="reference-text">Jim Edwards for BrandWeek. March 20, 2006. <i><a rel="nofollow" class="external text" href="https://web.archive.org/web/20060328121242/http://www.brandweek.com/bw/news/spotlight/article_display.jsp?vnu_content_id=1002199768">Bad Medicine.</a></i> BrandWeek. <a rel="nofollow" class="external text" href="http://www.brandweek.com/bw/news/spotlight/article_display.jsp?vnu_content_id=1002199768">Original link broken</a>, Created link from internet archive on August 9, 2014. Archive date March 28, 2006.</span>
</li>
<li id="cite_note-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-133">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://casetext.com/case/rost-v-pfizer-2">"Casetext"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Casetext&amp;rft_id=https%3A%2F%2Fcasetext.com%2Fcase%2Frost-v-pfizer-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-134">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20100528180040/http://www.pharmalot.com/2010/05/wyeth-targeted-blacks-with-illegal-marketing-lawsuit/">"Wyeth Marketing Targeted Blacks Illegally: Lawsuit // Pharmalot"</a>. Pharmalot.com. May 24, 2010. Archived from <a rel="nofollow" class="external text" href="http://www.pharmalot.com/2010/05/wyeth-targeted-blacks-with-illegal-marketing-lawsuit/">the original</a> on May 28, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Wyeth+Marketing+Targeted+Blacks+Illegally%3A+Lawsuit+%2F%2F+Pharmalot&amp;rft.pub=Pharmalot.com&amp;rft.date=2010-05-24&amp;rft_id=http%3A%2F%2Fwww.pharmalot.com%2F2010%2F05%2Fwyeth-targeted-blacks-with-illegal-marketing-lawsuit%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><cite class="citation web">Tracy Staton (June 14, 2010). <a rel="nofollow" class="external text" href="http://www.fiercepharma.com/story/congress-joins-probe-wyeths-rapamune-marketing/2010-06-14">"Congress joins probe into Wyeth's Rapamune marketing"</a>. FiercePharma<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Congress+joins+probe+into+Wyeth%27s+Rapamune+marketing&amp;rft.pub=FiercePharma&amp;rft.date=2010-06-14&amp;rft.au=Tracy+Staton&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Fcongress-joins-probe-wyeths-rapamune-marketing%2F2010-06-14&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercepharma.com/story/pfizer-settles-more-label-marketing-cases-tied-rapamune/2014-08-07">"Pfizer settles more off-label marketing cases tied to Rapamune - FiercePharma"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+settles+more+off-label+marketing+cases+tied+to+Rapamune+-+FiercePharma&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Fpfizer-settles-more-label-marketing-cases-tied-rapamune%2F2014-08-07&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><cite class="citation magazine">Petrovich, Dushko (March 15, 2013). <a rel="nofollow" class="external text" href="http://www.bookforum.com/review/11264">"<i>The Art of Making Magazines</i> edited by Victor S. Navasky and Evan Cornog"</a>. <i><a href="/wiki/Bookforum" title="Bookforum">Bookforum</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">March 18,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bookforum&amp;rft.atitle=The+Art+of+Making+Magazines+edited+by+Victor+S.+Navasky+and+Evan+Cornog&amp;rft.date=2013-03-15&amp;rft.aulast=Petrovich&amp;rft.aufirst=Dushko&amp;rft_id=http%3A%2F%2Fwww.bookforum.com%2Freview%2F11264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20101021043007/http://www.quigleyreorg.com/">The Quigley Company, Inc. Trust</a> Quigley Company reorganization</span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><cite class="citation book">Crown, Reign (2012). <a rel="nofollow" class="external text" href="https://books.google.com/?id=sjOiVvOButsC&amp;pg=PT124#v=onepage"><i>Master</i></a>. Booktango. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4689-2014-7" title="Special:BookSources/978-1-4689-2014-7"><bdi>978-1-4689-2014-7</bdi></a>. <q>over $965 million in settlements</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Master&amp;rft.pub=Booktango&amp;rft.date=2012&amp;rft.isbn=978-1-4689-2014-7&amp;rft.aulast=Crown&amp;rft.aufirst=Reign&amp;rft_id=https%3A%2F%2Fbooks.google.com%2F%3Fid%3DsjOiVvOButsC%26pg%3DPT124%23v%3Donepage&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><cite class="citation journal">Blackstone, E.H. (2005). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110608190524/http://circ.ahajournals.org/cgi/content/full/circulationaha;111/21/2717">"Could It Happen Again?: The Bjork–Shiley Convexo-Concave Heart Valve Story"</a>. <i>Circulation</i>. <b>111</b> (21): 2717–2719. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1161%2Fcirculationaha.105.540518">10.1161/circulationaha.105.540518</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15927988">15927988</a>. Archived from <a rel="nofollow" class="external text" href="http://circ.ahajournals.org/cgi/content/full/circulationaha;111/21/2717">the original</a> on June 8, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">June 21,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=Could+It+Happen+Again%3F%3A+The+Bjork%E2%80%93Shiley+Convexo-Concave+Heart+Valve+Story&amp;rft.volume=111&amp;rft.issue=21&amp;rft.pages=2717-2719&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1161%2Fcirculationaha.105.540518&amp;rft_id=info%3Apmid%2F15927988&amp;rft.aulast=Blackstone&amp;rft.aufirst=E.H.&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2Fcirculationaha%3B111%2F21%2F2717&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-141">^</a></b></span> <span class="reference-text"><cite class="citation journal">Bloomfield, P.;  et al. (1991). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/55874df97a7598d96f4f8af833c84e9028160b41">"Twelve-year comparison of a Bjork–Shiley mechanical heart valve with porcine bioprostheses"</a>. <i>N Engl J Med</i>. <b>324</b> (9): 573–579. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2Fnejm199102283240901">10.1056/nejm199102283240901</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1992318">1992318</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Twelve-year+comparison+of+a+Bjork%E2%80%93Shiley+mechanical+heart+valve+with+porcine+bioprostheses&amp;rft.volume=324&amp;rft.issue=9&amp;rft.pages=573-579&amp;rft.date=1991&amp;rft_id=info%3Adoi%2F10.1056%2Fnejm199102283240901&amp;rft_id=info%3Apmid%2F1992318&amp;rft.aulast=Bloomfield&amp;rft.aufirst=P.&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F55874df97a7598d96f4f8af833c84e9028160b41&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><cite id="CITEREFOldani2016" class="citation">Oldani, Michael (2016), <a rel="nofollow" class="external text" href="http://sk.sagepub.com/reference/the-sage-encyclopedia-of-pharmacology-and-society/i11727.xml">"Trovafloxacin (Trovan) Controversy"</a>, <i>The SAGE Encyclopedia of Pharmacology and Society</i>, SAGE Publications, Inc., pp. 1444–1447, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4135%2F9781483349985.n409">10.4135/9781483349985.n409</a>, <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9781483350004" title="Special:BookSources/9781483350004"><bdi>9781483350004</bdi></a><span class="reference-accessdate">, retrieved <span class="nowrap">January 21,</span> 2019</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Trovafloxacin+%28Trovan%29+Controversy&amp;rft.btitle=The+SAGE+Encyclopedia+of+Pharmacology+and+Society&amp;rft.pages=1444-1447&amp;rft.pub=SAGE+Publications%2C+Inc.&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.4135%2F9781483349985.n409&amp;rft.isbn=9781483350004&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fsk.sagepub.com%2Freference%2Fthe-sage-encyclopedia-of-pharmacology-and-society%2Fi11727.xml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><cite class="citation news">Murray, Senan (June 20, 2007). <a rel="nofollow" class="external text" href="http://news.bbc.co.uk/2/hi/africa/6768799.stm">"Africa | Anger at deadly Nigerian drug trials"</a>. <i>BBC News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Africa+%26%23124%3B+Anger+at+deadly+Nigerian+drug+trials&amp;rft.date=2007-06-20&amp;rft.aulast=Murray&amp;rft.aufirst=Senan&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fafrica%2F6768799.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><cite class="citation journal">Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956">"Sequelae due to bacterial meningitis among African children: a systematic literature review"</a>. <i>BMC Med</i>. <b>7</b>: 47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1741-7015-7-47">10.1186/1741-7015-7-47</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956">2759956</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19751516">19751516</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Med&amp;rft.atitle=Sequelae+due+to+bacterial+meningitis+among+African+children%3A+a+systematic+literature+review&amp;rft.volume=7&amp;rft.pages=47&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956&amp;rft_id=info%3Apmid%2F19751516&amp;rft_id=info%3Adoi%2F10.1186%2F1741-7015-7-47&amp;rft.aulast=Ramakrishnan&amp;rft.aufirst=M&amp;rft.au=Ulland%2C+AJ&amp;rft.au=Steinhardt%2C+LC&amp;rft.au=Mo%C3%AFsi%2C+JC&amp;rft.au=Were%2C+F&amp;rft.au=Levine%2C+OS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://news.bbc.co.uk/2/hi/business/1517171.stm">"Nigerians sue Pfizer over test deaths"</a>. <i>BBC News</i>. August 30, 2001<span class="reference-accessdate">. Retrieved <span class="nowrap">May 22,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Nigerians+sue+Pfizer+over+test+deaths&amp;rft.date=2001-08-30&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F1517171.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-DN-146"><span class="mw-cite-backlink">^ <a href="#cite_ref-DN_146-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DN_146-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.democracynow.org/2010/12/17/wikileaks_cables_pfizer_targeted_nigerian_attorney">WikiLeaks Cables: Pfizer Targeted Nigerian Attorney General to Undermine Suit over Fatal Drug Tests</a>, <i><a href="/wiki/Democracy_Now!" title="Democracy Now!">Democracy Now!</a></i></span>
</li>
<li id="cite_note-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-147">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.washingtonpost.com/wp-dyn/content/article/2006/05/06/AR2006050601338.html">Panel Faults Pfizer in '96 Clinical Trial In Nigeria</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i>. May 7, 2006</span>
</li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.cbsnews.com/news/pfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims/">"Pfizer Bribed Nigerian Officials in Fatal Drug Trial, Ex-Employee Claims - CBS News"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Bribed+Nigerian+Officials+in+Fatal+Drug+Trial%2C+Ex-Employee+Claims+-+CBS+News&amp;rft_id=http%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fpfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-149">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/files/news/trovan_statement_defense_summary.pdf">"Trovan, Kano State Civil Case – Statement Of Defense"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Trovan%2C+Kano+State+Civil+Case+%E2%80%93+Statement+Of+Defense&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Ffiles%2Fnews%2Ftrovan_statement_defense_summary.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-150">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://news.bbc.co.uk/2/hi/world/us_and_canada/10454982.stm">"Pfizer-Nigeria appeal dismissed"</a>. <i>BBC News</i>. June 29, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer-Nigeria+appeal+dismissed&amp;rft.date=2010-06-29&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fworld%2Fus_and_canada%2F10454982.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-151">^</a></b></span> <span class="reference-text"><cite class="citation news">Boseley, Sarah (December 9, 2010). <a rel="nofollow" class="external text" href="https://www.theguardian.com/business/2010/dec/09/wikileaks-cables-pfizer-nigeria">"WikiLeaks cables: Pfizer 'used dirty tricks to avoid clinical trial payout<span class="cs1-kern-right">'</span>"</a>. <i>The Guardian</i>. London.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=WikiLeaks+cables%3A+Pfizer+%27used+dirty+tricks+to+avoid+clinical+trial+payout%27&amp;rft.date=2010-12-09&amp;rft.aulast=Boseley&amp;rft.aufirst=Sarah&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2010%2Fdec%2F09%2Fwikileaks-cables-pfizer-nigeria&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-152">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://media.pfizer.com/files/news/the_guardian_nigeria_120910.pdf">"Press Statement Regarding Article in The Guardian"</a> <span class="cs1-format">(PDF)</span>. Pfizer. December 9, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">December 13,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Press+Statement+Regarding+Article+in+The+Guardian&amp;rft.pub=Pfizer&amp;rft.date=2010-12-09&amp;rft_id=http%3A%2F%2Fmedia.pfizer.com%2Ffiles%2Fnews%2Fthe_guardian_nigeria_120910.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.cbsnews.com/news/in-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols/">"In Defense of Blackmail: Why Shouldn't Pfizer Dig Dirt on Crooked Pols? - CBS News"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=In+Defense+of+Blackmail%3A+Why+Shouldn%27t+Pfizer+Dig+Dirt+on+Crooked+Pols%3F+-+CBS+News&amp;rft_id=http%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fin-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-154">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://saharareporters.com/2010/07/19/michael-aondoakaa-%E2%80%9Cunfit%E2%80%9D-remain-san-says-cdhr-high-powered-petition">"Michael Aondoakaa "Unfit" To Remain SAN, Says CDHR In High-Powered Petition | Sahara Reporters"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Michael+Aondoakaa+%22Unfit%22+To+Remain+SAN%2C+Says+CDHR+In+High-Powered+Petition+%26%23124%3B+Sahara+Reporters&amp;rft_id=http%3A%2F%2Fsaharareporters.com%2F2010%2F07%2F19%2Fmichael-aondoakaa-%25E2%2580%259Cunfit%25E2%2580%259D-remain-san-says-cdhr-high-powered-petition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-155"><span class="mw-cite-backlink"><b><a href="#cite_ref-155">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://usafricaonline.com/2010/12/12/wikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa/">"USAfrica: The Authoritative Link for Africans and Americans"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=USAfrica%3A+The+Authoritative+Link+for+Africans+and+Americans&amp;rft_id=http%3A%2F%2Fusafricaonline.com%2F2010%2F12%2F12%2Fwikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-156">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://archive.today/20120728144301/http://www.courant.com/news/connecticut/hc-pfizer-virus-lawsuit-0314.artmar14,0,5614508,print.story">"Ex-Pfizer Worker Cites Genetically Engineered Virus In Lawsuit Over Firing"</a>. Courant.com. March 14, 2010. Archived from <a rel="nofollow" class="external text" href="http://www.courant.com/news/connecticut/hc-pfizer-virus-lawsuit-0314.artmar14,0,5614508,print.story">the original</a> on July 28, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Ex-Pfizer+Worker+Cites+Genetically+Engineered+Virus+In+Lawsuit+Over+Firing&amp;rft.pub=Courant.com&amp;rft.date=2010-03-14&amp;rft_id=http%3A%2F%2Fwww.courant.com%2Fnews%2Fconnecticut%2Fhc-pfizer-virus-lawsuit-0314.artmar14%2C0%2C5614508%2Cprint.story&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://scholar.google.com/scholar_case?case=6796485641266292013">"McClain v. PFIZER, INC., 692 F. Supp. 2d 229"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 13,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=McClain+v.+PFIZER%2C+INC.%2C+692+F.+Supp.+2d+229&amp;rft_id=https%3A%2F%2Fscholar.google.com%2Fscholar_case%3Fcase%3D6796485641266292013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2010/04/03/business/03pfizer.html">"A Pfizer Whistle-Blower Is Awarded $1.4 Million"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. April 2, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">September 13,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Pfizer+Whistle-Blower+Is+Awarded+%241.4+Million&amp;rft.date=2010-04-02&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F04%2F03%2Fbusiness%2F03pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-159"><span class="mw-cite-backlink"><b><a href="#cite_ref-159">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://industry.bnet.com/pharma/10008499/blue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push/?tag=shell;content">"Blue Cross Names and Shames Pfizer Execs Linked to Massages-for-Prescriptions Push | BNET"</a>. Industry.bnet.com. June 10, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Blue+Cross+Names+and+Shames+Pfizer+Execs+Linked+to+Massages-for-Prescriptions+Push+%26%23124%3B+BNET&amp;rft.pub=Industry.bnet.com&amp;rft.date=2010-06-10&amp;rft_id=http%3A%2F%2Findustry.bnet.com%2Fpharma%2F10008499%2Fblue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push%2F%3Ftag%3Dshell%3Bcontent&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-160"><span class="mw-cite-backlink"><b><a href="#cite_ref-160">^</a></b></span> <span class="reference-text"><cite class="citation news">Bounds, Jeff (June 10, 2010). <a rel="nofollow" class="external text" href="http://www.bizjournals.com/austin/stories/2010/06/07/daily52.html">"Blue Cross Blue Shield of Texas sues Pfizer"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer&amp;rft.date=2010-06-10&amp;rft.aulast=Bounds&amp;rft.aufirst=Jeff&amp;rft_id=http%3A%2F%2Fwww.bizjournals.com%2Faustin%2Fstories%2F2010%2F06%2F07%2Fdaily52.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-161"><span class="mw-cite-backlink"><b><a href="#cite_ref-161">^</a></b></span> <span class="reference-text"><cite class="citation web">Tracy Staton (June 11, 2010). <a rel="nofollow" class="external text" href="http://www.fiercepharma.com/story/bcbs-names-pfizer-managers-kickback-suit/2010-06-11">"BCBS names Pfizer managers in kickback suit"</a>. FiercePharma<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BCBS+names+Pfizer+managers+in+kickback+suit&amp;rft.pub=FiercePharma&amp;rft.date=2010-06-11&amp;rft.au=Tracy+Staton&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Fbcbs-names-pfizer-managers-kickback-suit%2F2010-06-11&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-162"><span class="mw-cite-backlink"><b><a href="#cite_ref-162">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.dallasnews.com/sharedcontent/dws/bus/stories/DN-bcbs_11bus.ART0.State.Edition1.1aad2e1.html">"Blue Cross Blue Shield of Texas sues Pfizer over drug marketing | News for Dallas, Texas | Dallas Morning News | Dallas Business News"</a>. Dallasnews.com. June 11, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer+over+drug+marketing+%26%23124%3B+News+for+Dallas%2C+Texas+%26%23124%3B+Dallas+Morning+News+%26%23124%3B+Dallas+Business+News&amp;rft.pub=Dallasnews.com&amp;rft.date=2010-06-11&amp;rft_id=http%3A%2F%2Fwww.dallasnews.com%2Fsharedcontent%2Fdws%2Fbus%2Fstories%2FDN-bcbs_11bus.ART0.State.Edition1.1aad2e1.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-163"><span class="mw-cite-backlink"><b><a href="#cite_ref-163">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2014-06-02/pfizer-agrees-to-325-million-settlment-over-neurontin.html">"Pfizer Agrees to $325 Million Neurontin Marketing Accord - Bloomberg"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Agrees+to+%24325+Million+Neurontin+Marketing+Accord+-+Bloomberg&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-06-02%2Fpfizer-agrees-to-325-million-settlment-over-neurontin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-164">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.ajc.com/health/pfizer-settles-lawsuit-involving-1429314.html">Pfizer Settles Lawsuite</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120601055014/http://www.ajc.com/health/pfizer-settles-lawsuit-involving-1429314.html">Archived</a> 1 June 2012 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-Kelo-165"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kelo_165-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kelo_165-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.law.cornell.edu/supct/html/04-108.ZO.html">"Kelo V. New London (04-108) 545 U.S. 469 (2005) 268 Conn. 1, 843 A. 2d 500, affirmed"</a>. <i>Cornell University Law School</i><span class="reference-accessdate">. Retrieved <span class="nowrap">November 27,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Cornell+University+Law+School&amp;rft.atitle=Kelo+V.+New+London+%2804-108%29+545+U.S.+469+%282005%29+268+Conn.+1%2C+843+A.+2d+500%2C+affirmed.&amp;rft_id=https%3A%2F%2Fwww.law.cornell.edu%2Fsupct%2Fhtml%2F04-108.ZO.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-166"><span class="mw-cite-backlink"><b><a href="#cite_ref-166">^</a></b></span> <span class="reference-text"><cite class="citation news">Mcgeehan, Patrick (November 12, 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/11/13/nyregion/13pfizer.html">"Pfizer and 1,400 Jobs to Leave New London, Connecticut"</a>. <i>The New York Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+and+1%2C400+Jobs+to+Leave+New+London%2C+Connecticut&amp;rft.date=2009-11-12&amp;rft.aulast=Mcgeehan&amp;rft.aufirst=Patrick&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F11%2F13%2Fnyregion%2F13pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-167"><span class="mw-cite-backlink"><b><a href="#cite_ref-167">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/press-releases/pfizer-commended-leadership-addressing-climate-change-third-consecutive-year">"Pfizer Commended For Leadership In Addressing Climate Change For Third Consecutive Year - FierceBiotech"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Commended+For+Leadership+In+Addressing+Climate+Change+For+Third+Consecutive+Year+-+FierceBiotech&amp;rft_id=http%3A%2F%2Fwww.fiercebiotech.com%2Fpress-releases%2Fpfizer-commended-leadership-addressing-climate-change-third-consecutive-year&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-168"><span class="mw-cite-backlink"><b><a href="#cite_ref-168">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_recognized_by_carbon_disclosure_project_for_carbon_performance">"Pfizer Recognized by Carbon Disclosure Project for Carbon Performance | Pfizer: One of the world's premiere biopharmaceutical companies"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Recognized+by+Carbon+Disclosure+Project+for+Carbon+Performance+%26%23124%3B+Pfizer%3A+One+of+the+world%27s+premiere+biopharmaceutical+companies&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-archive-detail%2Fpfizer_recognized_by_carbon_disclosure_project_for_carbon_performance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-169"><span class="mw-cite-backlink"><b><a href="#cite_ref-169">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.nj.gov/dep/srp/community/sites/pi/american_cyanamid_fs.pdf">"American Cyanamid Superfund Site"</a> <span class="cs1-format">(PDF)</span>. <i>The State of New Jersey</i>. December 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">November 27,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+State+of+New+Jersey&amp;rft.atitle=American+Cyanamid+Superfund+Site&amp;rft.date=2011-12&amp;rft_id=http%3A%2F%2Fwww.nj.gov%2Fdep%2Fsrp%2Fcommunity%2Fsites%2Fpi%2Famerican_cyanamid_fs.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-170"><span class="mw-cite-backlink"><b><a href="#cite_ref-170">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.nj.com/news/index.ssf/2012/03/activisits_say_epa_fix_for_pol.html">"Activists say EPA $204M fix for polluted American Cyanamid property will not permanently resolve problem | NJ.com"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Activists+say+EPA+%24204M+fix+for+polluted+American+Cyanamid+property+will+not+permanently+resolve+problem+%26%23124%3B+NJ.com&amp;rft_id=http%3A%2F%2Fwww.nj.com%2Fnews%2Findex.ssf%2F2012%2F03%2Factivisits_say_epa_fix_for_pol.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-autogenerated3-171"><span class="mw-cite-backlink"><b><a href="#cite_ref-autogenerated3_171-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.washingtonpost.com/wp-dyn/content/article/2006/05/23/AR2006052301305_pf.html">The tempest</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i>. May 28, 2006</span>
</li>
<li id="cite_note-172"><span class="mw-cite-backlink"><b><a href="#cite_ref-172">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.usglc.org/about/our-coalition">"U.S. Global Leadership Coalition, Global Trust members"</a>. Usglc.org<span class="reference-accessdate">. Retrieved <span class="nowrap">July 11,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=U.S.+Global+Leadership+Coalition%2C+Global+Trust+members&amp;rft.pub=Usglc.org&amp;rft_id=http%3A%2F%2Fwww.usglc.org%2Fabout%2Four-coalition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-173"><span class="mw-cite-backlink"><b><a href="#cite_ref-173">^</a></b></span> <span class="reference-text">Steinbrook, R., 2009. <a rel="nofollow" class="external text" href="http://healthcarereform.nejm.org/?p=2358">Lobbying, Campaign Contributions, and Health Care Reform</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100610045933/http://healthcarereform.nejm.org/?p=2358">Archived</a> June 10, 2010, at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>  New England Journal of Medicine. 361(23), e52–e52.</span>
</li>
<li id="cite_note-NZ_Herald_10695239-174"><span class="mw-cite-backlink"><b><a href="#cite_ref-NZ_Herald_10695239_174-0">^</a></b></span> <span class="reference-text"><cite class="citation news">David Fisher &amp; Jonathan Milne (December 19, 2010). <a rel="nofollow" class="external text" href="http://www.nzherald.co.nz/pharmaceuticals/news/article.cfm?c_id=278&amp;objectid=10695239">"WikiLeaks: Drug firms tried to ditch Clark"</a>. <i><a href="/wiki/The_New_Zealand_Herald" title="The New Zealand Herald">The New Zealand Herald</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">November 3,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+Zealand+Herald&amp;rft.atitle=WikiLeaks%3A+Drug+firms+tried+to+ditch+Clark&amp;rft.date=2010-12-19&amp;rft.au=David+Fisher&amp;rft.au=Jonathan+Milne&amp;rft_id=http%3A%2F%2Fwww.nzherald.co.nz%2Fpharmaceuticals%2Fnews%2Farticle.cfm%3Fc_id%3D278%26objectid%3D10695239&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-175"><span class="mw-cite-backlink"><b><a href="#cite_ref-175">^</a></b></span> <span class="reference-text"><cite class="citation news">Mishra, Manas (July 2, 2019).  Kuber, Shailesh (ed.). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-pfizer-board-scott-gottlieb/senator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX">"Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board"</a>. Reuters<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Senator+Warren+asks+former+FDA+chief+Gottlieb+to+resign+from+Pfizer+board&amp;rft.date=2019-07-02&amp;rft.aulast=Mishra&amp;rft.aufirst=Manas&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-board-scott-gottlieb%2Fsenator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-176"><span class="mw-cite-backlink"><b><a href="#cite_ref-176">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120417084851/http://www.canadastop100.com/montreal/montreal2012.pdf">"Montreal's Top Employers 2012"</a> <span class="cs1-format">(PDF)</span>. Canada's Top 100. 2012. Archived from <a rel="nofollow" class="external text" href="http://www.canadastop100.com/montreal/montreal2012.pdf">the original</a> <span class="cs1-format">(PDF)</span> on April 17, 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Montreal%27s+Top+Employers+2012&amp;rft.pub=Canada%27s+Top+100&amp;rft.date=2012&amp;rft_id=http%3A%2F%2Fwww.canadastop100.com%2Fmontreal%2Fmontreal2012.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-177"><span class="mw-cite-backlink"><b><a href="#cite_ref-177">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://onpartners.com/2019/01/21/on-partners-announces-top-executive-moves-of-2018/">"ON PARTNERS ANNOUNCES TOP EXECUTIVE MOVES OF 2018"</a>. <i>ON Partners</i>. January 21, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">April 3,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ON+Partners&amp;rft.atitle=ON+PARTNERS+ANNOUNCES+TOP+EXECUTIVE+MOVES+OF+2018&amp;rft.date=2019-01-21&amp;rft_id=https%3A%2F%2Fonpartners.com%2F2019%2F01%2F21%2Fon-partners-announces-top-executive-moves-of-2018%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-The_New_York_Times-178"><span class="mw-cite-backlink"><b><a href="#cite_ref-The_New_York_Times_178-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2001/06/07/world/aids-fungus-drug-offered-to-poor-nations.html">"AIDS Fungus Drug Offered to Poor Nations"</a>. June 7, 2001<span class="reference-accessdate">. Retrieved <span class="nowrap">August 10,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=AIDS+Fungus+Drug+Offered+to+Poor+Nations&amp;rft.date=2001-06-07&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2001%2F06%2F07%2Fworld%2Faids-fungus-drug-offered-to-poor-nations.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-179"><span class="mw-cite-backlink"><b><a href="#cite_ref-179">^</a></b></span> <span class="reference-text"><cite class="citation web">Sithole, Emelia (February 21, 2001). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20070929091937/http://ww4.aegis.org/news/re/2001/RE010226.html">"S.Africa okays Pfizer AIDS drug distribution"</a>. Reuters NewMedia. Archived from <a rel="nofollow" class="external text" href="http://ww4.aegis.org/news/re/2001/RE010226.html">the original</a> on September 29, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">May 15,</span> 2006</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=S.Africa+okays+Pfizer+AIDS+drug+distribution&amp;rft.pub=Reuters+NewMedia&amp;rft.date=2001-02-21&amp;rft.aulast=Sithole&amp;rft.aufirst=Emelia&amp;rft_id=http%3A%2F%2Fww4.aegis.org%2Fnews%2Fre%2F2001%2FRE010226.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-180"><span class="mw-cite-backlink"><b><a href="#cite_ref-180">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/responsibility/global_health/diflucan_partnership_program">"Pfizer - Diflucan Commitments"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 9,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+-+Diflucan+Commitments&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fresponsibility%2Fglobal_health%2Fdiflucan_partnership_program&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-181"><span class="mw-cite-backlink"><b><a href="#cite_ref-181">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pfizer.com/health/vaccines/developing_world">"Pfizer - GAVI commitments"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 9,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+-+GAVI+commitments&amp;rft_id=http%3A%2F%2Fwww.pfizer.com%2Fhealth%2Fvaccines%2Fdeveloping_world&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-182"><span class="mw-cite-backlink"><b><a href="#cite_ref-182">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.gatesfoundation.org/media-center/press-releases/2012/07/innovative-partnership-to-deliver-convenient-contraceptives-to-up-to-three-million-women">"Pfizer Gates Foundation Press Release"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 9,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Gates+Foundation+Press+Release&amp;rft_id=http%3A%2F%2Fwww.gatesfoundation.org%2Fmedia-center%2Fpress-releases%2F2012%2F07%2Finnovative-partnership-to-deliver-convenient-contraceptives-to-up-to-three-million-women&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(14)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=38" title="Edit section: External links" data-section="38" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-14 collapsible-block" id="mf-section-14">
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Pfizer" class="extiw" title="commons:Category:Pfizer"><span style="">Pfizer</span></a></b></i>.</td></tr></tbody></table><ul><li><span class="official-website"><span class="url"><a rel="nofollow" class="external text" href="http://www.pfizer.com/">Official website</a></span></span> <a href="https://www.wikidata.org/wiki/Q206921#P856" title="Edit this at Wikidata"><noscript><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" data-file-width="20" data-file-height="20"></noscript><span class="lazy-image-placeholder" style="width: 10px;height: 10px;" data-src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" data-alt="Edit this at Wikidata" data-width="10" data-height="10" data-srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x"> </span></a></li>
<li>Business data for Pfizer: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=PFE">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=PFE">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=PFE">SEC filings</a></li></ul></div></li></ul>






</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Pfizer&amp;oldid=951294906">https://en.wikipedia.org/w/index.php?title=Pfizer&amp;oldid=951294906</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Pfizer"
				data-user-name="OAbot"
				data-user-gender="unknown"
				data-timestamp="1587043173">
				<span>Last edited on 16 April 2020, at 13:19</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Pfizer&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.668","walltime":"2.034","ppvisitednodes":{"value":9006,"limit":1000000},"postexpandincludesize":{"value":328013,"limit":2097152},"templateargumentsize":{"value":8206,"limit":2097152},"expansiondepth":{"value":16,"limit":40},"expensivefunctioncount":{"value":15,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":524741,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 1761.847      1 -total"," 52.45%  924.050      1 Template:Reflist"," 22.30%  392.853     92 Template:Cite_web"," 10.31%  181.597      1 Template:Infobox_company","  9.45%  166.541      1 Template:Infobox","  9.22%  162.364     42 Template:Cite_news","  6.81%  119.997     14 Template:Cite_journal","  4.46%   78.516      1 Template:Coord","  3.45%   60.871      1 Template:Short_description","  3.34%   58.794      4 Template:Citation_needed"]},"scribunto":{"limitreport-timeusage":{"value":"0.925","limit":"10.000"},"limitreport-memusage":{"value":14390910,"limit":52428800}},"cachereport":{"origin":"mw1384","timestamp":"20200417171049","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Pfizer","url":"https:\/\/en.wikipedia.org\/wiki\/Pfizer","sameAs":"http:\/\/www.wikidata.org\/entity\/Q206921","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q206921","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2002-07-15T03:25:40Z","dateModified":"2020-04-16T13:19:33Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/e\/e3\/Pfizer.svg","headline":"American multinational pharmaceutical corporation"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":202,"wgHostname":"mw1331"});});</script>		</body>
		</html>
		